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ABSTRACT

CHARACTERIZATION OF THE INNATE RESPONSE TO THE RAGB PROTEIN
OF PORPHYROMONAS GINGIVALIS
By
Justin Hutcherson

December 19th 2014

More than 64 million people in the US suffer from some form of periodontal
disease. Periodontal diseases are bacterial infections of the hard and soft tissues
surrounding the teeth which can lead to tooth loss. Periodontal tissue destruction is
caused by inflammatory host-pathogen interactions. Porphyromonas gingivalis is a
major causative agent of periodontal diseases and is a keystone periodontal pathogen.
The 55kDa immunodominant RagB outer membrane protein of P. gingivalis has been
proposed to facilitate iron transport. However, potential interactions between RagB and
the innate response have not been examined. RagB homologues in gut Bacteroidetes
have been associated with inflammatory bowel disease. Therefore, we hypothesized that
RagB aids in virulence of P. gingivalis and elicits a pro-inflammatory host response in
innate cells.
We determined that RagB exposure led to the differential and dose-related
expression of multiple genes encoding pro-inflammatory mediators (IL-1β, IL-6, IL-8,
v

and CCL2) in primary human monocytes and to the secretion of TNF, IL-6 and
IL-8. RagB was shown to be a TLR2 and TLR4 agonist that activated STAT4 and NFκB
transcription factors. ∆ragB mutants also induced a reduced inflammatory response
compared to the wild type strain as well as reduced survivability when exposed to oral
epithelial cells which adds evidence to the role of ragB in epithelial cell colonization.
These results suggest that ragB elicits a major pro-inflammatory response in primary
human monocytes and therefore could play an important role in the etiology of
periodontitis and systemic sequelae.
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CHAPTER ONE: INTRODUCTION

Chronic Inflammatory Diseases
The innate immune response must be tightly regulated and able to distinguish
between foreign and domestic antigens. Pathogens elicit innate responses but when the
pathogen has been cleared the response must be turned off to prevent host cell and tissue
destruction. The central nervous system (CNS) regulates a feedback loop that optimizes
innate inflammatory responses. Glucocorticoids are anti-inflammatory molecules that are
released to terminate inflammation. The NFκB pathway can be shut off by the interaction
of RelA (p65) with glucorticoids, which induce IkB and stop the production of proinflammatory cytokines [1]. If the response is left unchecked, then this can lead to the
disruption of homeostasis and result in autoimmune diseases, cancers, septic shock and
multiple chronic inflammatory diseases [2].
According to the CDC, 7 out of 10 people in the US die of a chronic disease.
Chronic inflammatory diseases are defined as long term inflammatory processes that are
directed at particular endogenous or exogenous stimuli. Pathogens that are able to persist
and avoid being destroyed by the host can lead to the progression of chronic
inflammation. Diet and lifestyle also play a major role in chronic inflammatory diseases
[3]. Obesity, which affects more than one third of adults in the US, is a risk factor for
chronic inflammatory disease. With the increase in fat cells, the output of inflammatory
1

molecules is increased and this can result in insulin resistance leading to diabetes
and other diseases [4].
Chronic inflammation leads to many chronic diseases including inflammatory
bowel disease (IBD), periodontitis, type I diabetes, stroke, and many other chronic
conditions. There are many studies investigating strategies to control and down regulate
inflammatory responses. A major target for anti-inflammatory therapeutic treatment is
the transcription regulator, NFκB. NFκB plays a central role in inflammatory processes
and numerous papers have shown NFκB to be a potential therapeutic agent for chronic
inflammation [5-7]. For example, resveratrol, a natural polyphenol associated with antiinflammatory effects, has been shown to inhibit the progression of Alzheimer’s disease
by interfering with TLR4/NFκB/STAT pathways [8]. Other transcriptional pathways are
being investigated to be used for anti-inflammatory therapies. Signal transducer and
activator of transcription 4 (STAT4) is a major inflammatory mediator. STAT4 has been
shown to be necessary in the differentiation of B cells [9] and regulatory T cells [10].
STAT4 plays a significant role in autoimmune diseases such as rheumatoid arthritis [11],
inflammatory bowel disease [12], and type I diabetes [13]. STAT4 is a target of
lisofylline (LSF) for anti-diabetic effects [14] which has been shown to inhibit STAT4
activation through IL-12 signaling. Lisofylline has also been shown to be useful in the
prevention of type 1 diabetes in C57BL/6 mice [15].
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Periodontal diseases
Chronic periodontitis, characterized by the destruction of the hard and soft
tissues surrounding the teeth, is predominantly caused by the immune response to
pathogenic bacteria present in the dental plaque. Periodontitis and gingivitis are
periodontal diseases that contribute to a major economic burden worldwide. According
to the World Health Organization, >60% of the population aged 35-44 years of age in the
Americas have some form of periodontitis [16]. Gingivitis is a periodontal disease that
is characterized by inflammation around the teeth, and if left untreated can lead to
periodontitis. The economic burden of periodontal diseases in the US is more than $14
billion per annum [17]. More than 50% of the population in the US will have some form
of periodontal disease in their lifetime [18]. People over the age of 60 have a greater than
65% chance of having periodontitis. More than 64 million people in the US have some
form of periodontitis [19].
There are many risk factors that contribute to periodontal diseases. Poor oral
hygiene, immunodeficiency, age, diabetes [20] and smoking [21] are all factors that can
increase susceptibility to periodontal diseases [22, 23]. Smoking is a major risk factor for
multiple diseases, in part, due to the massive number of carcinogens and toxins found in
tobacco and tobacco smoke. Smoking is the greatest environmental risk factor for
periodontal diseases. Smokers display a more severe form of periodontitis and are more
refractory to treatment than non-smokers [24, 25]. Smoking also leads to a pathogenenriched oral microbiota [26].
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Tissue destruction is caused by a combination of bacterial insult and the host
immune response to dental plaque. Host cells release cytokines, proteases, and other
factors which both combat pathogens and destroy tissue and host cells. Bacteria, on the
other hand, utilize an array of factors, such as the release of enzymes and toxins to
increase their survivability in the host, some of which can cause host tissue destruction.
The microbiome of healthy individuals consists of mainly aerobic Gram-positive
bacteria, with a shift towards anaerobic Gram-negative bacteria noted in the diseased
state [27]. Bacteria are able to colonize the junction between the tooth and oral
epithelium and form biofilms, which make up dental plaque and lead to dental caries.
Dental plaque consists of bacterial communities that lead to the destruction of enamel on
the tooth by the release of metabolites produced from the breakdown of sugars by the
bacteria. Once the enamel is destroyed, dentin is exposed and bone destruction occurs
more rapidly. Bacterial biofilms protect the bacteria from host responses and allow
bacteria to persist and further colonize the host. Biofilms contain specific niches that
allow for a diversity of bacteria to survive. These environments provide nutrient
gradients, various pH levels, and aerobic-anaerobic environments. Biofilms also protect
from phagocytosis and antibiotics [28, 29].
Periodontal diseases are a risk factor for an array of diseases such as stroke [30,
31], pulmonary diseases [32, 33], rheumatoid arthritis [34], and pre-term birth [35-37].
Traditionally, the major causative agents of periodontal diseases were the “red complex”
which included Tannerella forsythia, Treponema denticola and Porphyromonas
gingivalis [38]. This concept has been recently superseded by the “keystone pathogen”
hypothesis. Keystone pathogens are those of relatively low number within the
4

microbiome which cause a disruption in the symbiosis of the normal flora leading to a
more pathogenic state [39]. P. gingivalis has evolved strategies to impair the innate
immunity by altering the entire biofilm and disrupting homeostatic host-microbial
interactions in the periodontium [39, 40].
Porphyromonas gingivalis
Porphyromonas gingivalis, a Gram-negative, assaccharolytic anaerobe, is a
causative agent of chronic periodontitis and a keystone pathogen of the sub-gingival
biofilm [41]. P. gingivalis has also been associated with other diseases such as diabetes
[20], rheumatoid arthritis [34], and other chronic inflammatory diseases [42].
P. gingivalis employs many factors in its colonization of the oral cavity including
the secretion of proteinase enzymes called gingipains that are capable of degrading host
cell receptors, complement proteins, and other host components [43]. P. gingivalis is also
very efficient in forming biofilms. Biofilms play a major role in the colonization of the
oral cavity allowing bacteria to form specialized niches. Anaerobes are protected from
oxygen rich environments by aerobic bacteria that are found on the outer layers of the
biofilm. Biofilms also protect bacteria against antibiotics and against phagocytosis by
host immune cells. Dental plaque is a bacterial biofilm that forms on the surface of the
tooth and epithelium aiding the oral pathogens in disease progression.
Because P. gingivalis is assaccharolytic, it is unable to break down carbohydrates
for energy, therefore, it needs to acquire nutrients from the environment [44]. P.
gingivalis is able to obtain amino acids from the subgingival environment due to
secretion of proteases, along with other oral bacterial and host-derived proteases. The
5

destruction of connective tissue caused by the inflammatory response leads to a release of
nutrients necessary for survival of P. gingivalis. Thus, the immune response
involuntarily aids P. gingivalis survival by providing essential nutrients that would not
normally be available.

Virulence Factors of Porphyromonas gingivalis
P. gingivalis has an arsenal of virulence factors which aid in its ability to
colonize, establish infection and cause disease. These factors include capsule production,
secretion of gingipains, LPS, fimbrial proteins and the rag locus [45].
Capsule: To avoid phagocytosis, some P. gingivalis strains produce a negatively charged
polysaccharide capsule. There are six capsule serotypes (K1-K6) found in P. gingivalis
[46]. The W83 strain used in this study contains the K1 serotype. The extracellular
capsule aids the bacteria in the resistance to being engulfed by neutrophils and other
phagocytes of the immune system [47, 48]. A recent study showed a non-encapsulated
mutant to be significantly more invasive than the wild type strain in human gingival
fibroblasts, allowing it to avoid being killed by antibiotics [49]. Studies have also shown
variations between serotypes of encapsulated strains differentially regulate the host
immune response. Encapsulated strains had a higher virulence in a mouse abscess model
when compared to non-encapsulated strains [48, 50]. Thus, expression of the
polysaccharide capsule may be beneficial for survival within the host both upregulated
and downregulated.
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Gingipains: P. gingivalis produces three cysteine proteases called gingipains. The
gingipains include: RgpA and RgpB which are arginine-specific, and Kgp which is lysine
specific [51, 52]. Gingipains are considered housekeeping proteases of P. gingivalis
since they are able to degrade proteins into peptides which can then be used for growth
and metabolism [43]. Gingipains utilize free amino acids as a source of carbon and
nitrogen [53]. Gingipains are a major virulence factor that aids in attachment and
colonization, evasion of host defenses, and tissue invasion and dissemination. A recent
study comparing wild type with a gingipain deficient mutant has showed gingpains play
an important role in intracellular survival [54]. Gingipains are also able to degrade
multiple complement components and host cell receptors to subvert the immune response
[55, 56].
LPS: P. gingivalis is atypical in that it is structurally different from typical
enterobacterial LPS such as that found in E. coli. P. gingivalis LPS contains lipid A
heterogeneity containing tetra-(LPS1435/1449) and penta-(LPS1690) acylated forms [57, 58].
P. gingivalis LPS has been shown to differentially activate TLR4-mediated NFκB which
modulates expression of IL-6 and IL-8 in human gingival fibrobasts [59]. P. gingivalis
LPS can signal inflammatory cytokines through both TLR2 and -4 [58, 59]. The
LPS1435/1449 tetra form has been shown to weakly activate the immune response, while the
LPS1690 penta form induces a much stronger inflammatory response [60]. Altering its
lipid A structure contributes to P. gingivalis’ ability to evade the innate host’s defenses.
Fimbrial proteins: Fimbriae are fine, numerous appendices that protrude from the outer
cell membrane. P. gingivalis produces several fimbrial proteins, including the major
fimbrial antigen (FimA) and minor fimbrial antigen (Mfa1). Mfa1, 67 kDa protein, are
7

shorter filaments (18-120nm) [61] and FimA,41kDa protein, are longer filaments (0.5-1
µm) [62]. Both are considered virulence factors that aid in adherence and invasion of
tissue [62, 63]. A recent study which used an in vitro biofilm model, showed fimbrial
proteins aid P. gingivalis in binding to a primary oral colonizer, Streptococcus gordonii
[64]. Both types of fimbriae stimulate pro-inflammatory cytokines though distinct TLR2
pathways [65, 66]. Mfa1 has been shown to target C-type lectin receptors for invasion in
monocyte-derived cells [67]. Our lab has shown FimA abrogates the pro-inflammatory
response to TLR2 stimulation by other TLR2 specific agonists. We have also shown a
differential expression of fimbrial proteins in response to the environmental stress of
tobacco smoke [65].
rag locus
The rag locus of P. gingivalis is comprised of receptor antigen A (ragA, PG0185),
encoding a 115 kDa TonB-dependent receptor, and ragB (PG0186), encoding a 55 kDa
putative lipoprotein (Figure 1) [68]. The rag proteins are homologous to the starch
utilization system proteins, SusC and SusD, respectively, of gut Bacteroidetes [69]. The
rag genes are co-transcribed, flanked by insertion sequences, and consist of a lower G+C
ratio than the rest of the genome, suggesting the rag locus is a pathogenicity island that
arose from horizontal transfer [68, 70].
The exact function of the rag locus has yet to be determined. RagA spans the
outer membrane forming a beta-barrel like structure and is believed to be linked to a
TonB-like protein, whereas RagB is exposed on the outer surface of the membrane in a
complex with RagA [68]. The closest homolog is the Sus system that is involved in the
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transportation and utilization of starch and other complex molecules [70], but it is still
unclear of the role the rag locus plays in nutrient acquisition. It has been hypothesized
that the rag locus aids iron acquisition since it is analogous to transferrin binding systems
found in Neisseria and Haemophilus species which contain a TonB-linked outer
membrane protein (i.e. ragA) that is cotranscribed with a outermembrane lipoprotein (i.e.
ragB) [68].
While host-RagB interactions are poorly understood, a recent study using P.
gingivalis cell lysate and serum from patients with periodontitis has shown that RagB is
the most immunodominant P. gingivalis antigen, and is clearly recognized by the immune
system [71]. Recent data suggest that the rag operon may be essential for survival in
vitro to P. gingivalis using a mariner transposon system [72].

Figure 1. rag locus. A schematic diagram of the rag locus and flanking genes in P.
gingivalis [68]. The rag locus consists of ragA and ragB genes which are flanked by an
insertion sequence (IS1126). ragA contains a TonB box site and ragB contains a motif
indicative to lipoproteins.
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RagB is frequently found in P. gingivalis from periradicular lesions, [73] and is
mostly commonly found in the strains isolated by deeper pocket depths using PCR
analysis of subgingival plaque samples from periodontal patients and healthy control
individuals[68]. This association suggests that rag aids the bacterium in establishing a
more severe form of disease due to being found more frequently in deep pockets. rag
mutants have been shown to be less virulent in a dorsal subcutaneous mouse model [74,
75]. Ulcer sizes were significantly smaller in mice infected with rag mutants with very
few bacteria recovered from the spleen, compared to the wild type [74]. Another group
demonstrated rag knockout mutants inoculated by a dorsal subcutaneous infection had a
significantly higher survival rate when compared to the wild type strain [75]. This
suggests the rag locus could be a major virulence factor in vivo.
RagB is under investigation as a potential periodontitis vaccine. Zheng et.al used
eukaryotic expression vector (pIRES) gene-linked to ragB as a DNA vaccine and showed
mice inoculated intramuscularly with a ragB-linked DNA vaccine produced a strong antiRagB antibody response, were strongly resistant to P. gingivalis infection and displayed a
significant reduction in lesion size compared to the control group [76]. RagB is also
considered to play a essential role in the invasion of KB (HeLa-derived continuous cell
line) cells based on genomic comparison of invasive and non-invasive strains using
genomic hybridization arrays [77].

10

Innate Immune Response
Humans are constantly exposed to microbes that have the ability to cause
infection and disease. The immune system has evolved to recognize and respond to the
invading microbes, and to establish long term memory for certain pathogens. The two
main arms of the immune system are innate immunity and adaptive immunity, which
work in concert to eliminate potential pathogens.
The adaptive immune response involves immune memory and is highly specific
for particular pathogen-derived antigens. The innate immune response, on the other
hand, relies on its ability to recognize common molecules of invading microbes. Pattern
recognition receptors (PRRs) on host cells recognize highly conserved microbeassociated molecular patterns (MAMPs) [78]. Toll-like receptors (TLRs), C-type lectin
receptors (CLRs), nucleotide-binding and oligomerization domain (NOD)-like receptors
(NLRs) and retinoic acid-inducible gene I-like receptors (RIGs) are all PRRs that are
expressed to recognize potential pathogens [79-81]. RIGs, NLRs and some TLRs are
intracellular receptors while CLRs and other TLRs are membrane bound surface exposed
receptors [82, 83].
Humans express ten known TLRs in epithelial, endothelial and leukocyte
subtypes. Some TLRs can form complexes with other TLRs such as TLR2, which is
capable of forming heterodimers with both TLR1 and -6. Agonists of TLRs include
triacyl lipopeptides, dsDNA, LPS, flagellin, diacyl lipopeptides, imidazoquinoline
amines, ssRNA, and unmethylated CpG DNA which are recognized by TLR2/1, -3, -4, 5, -2/6, -7, -8 and -9, respectively. The TLR10 agonist is still unknown [84-86]. The
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major surface TLRs are TLR2/4/5, which are the focus herein. All TLR signaling
pathways result in activation of the transcription factor NFκB (nuclear factor-κB) via the
myeloid differentiation primary response 88 (MyD88) or TIR-domain-containing
adapter-inducing interferon-β (TRIF) (Figure 2). MyD88 and TRIF are the major
adaptors that bind to the intracellular domain of TLRs [87, 88]. TLRs use different
combinations of adaptors to activate unique pathways for the elimination of pathogens
[89, 90]. Once a MAMP is recognized by PRRs on innate immune cells, an
inflammatory response is elicited at the site of infection. Neutrophils and
macrophages/monocytes are primary responders of the innate system. They have the
ability to phagocytize antigens and release molecules for the recruitment of additional
immune cells and other molecules to destroy the invading microbe [91, 92].
As our immune system has evolved to combat microbes, microbes have adapted
strategies of their own to subvert the immune system. Several strategies are utilized in
avoidance of the immune system including secretion of proteases to degrade cytokines
and host receptors, modification of the molecular structure of their MAMPs to avoid
recognition by PRRs and protein secretion systems that deliver virulence factors into the
host cells to down regulate immune responses.
Certain pathogens are capable of targeting major signal transduction pathways,
including the NFκB and MAPK pathways. Bacillius anthracis lethal factor (LF) directly
inhibits MAPK pathways by cleaving the amino terminus on MAPKK1 and -2 [93].
Shigella spp. are capable of surviving within host macrophages where they inhibit the
NFκB pro-inflammatory pathway through release of its Type III effector molecule, OspL
[94]. Extracellular bacteria such as enterohemorrhagic Escherichia coli (EHEC) also
12

inhibit the MAPK-NFκB pathway by releasing translocated intimin receptor (Tir) into the
host. Tir mimics immunoreceptor tyrosine-based inhibition motifs (ITIMs), which leads
to the recruitment of Src-homology-region-2-domain-containing phosphatase 1 (SHP-1)
that directly dephosphorylates NFκB and MAPK [95].
While it has been established that RagB is recognized by the immune system, the
inflammatory potential of RagB is unknown. The main objective of this study was to
determine the inflammatory potential of RagB and to unravel any underlying proinflammatory mechanisms. We determined that RagB elicits a pro-inflammatory
response, via TLR-2 and -4, and activates transcription factors STAT4 and NFκB, which
then leads to production of pro-inflammatory mediators at the transcriptional and protein
levels including IL-6, TNF and IL-8. We also add evidence to the important role of ragB
in P. gingivalis invasion of oral epithelial cells using a ragB knockout mutant.
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Figure 2. Activation of the NFκB pathway by TLR2 and -4.
Diagram represents the activation of NFκB complex via surface expressed TLR2 and -4
in a human monocyte. Agonists recognized by TLRs lead to the phosphorylation of IκB
which then degrades allowing the p50/p65 complex to travel directly to the nucleus for
transcription and/or allow binding to STAT4 which then can activate transcription.
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CHAPTER TWO: MATERIALS AND METHODS

Materials
Gifu Anaerobe Medium (GAM) was purchased from Nissui Pharmaceutical (Tokyo,
Japan). ∆ragB and ∆ragB/W83 complement strains were a generous gift from Dr.
Fuminobu Yoshimura [74]. P. gingivalis specific antibodies were a kind gift from Dr.
Richard Lamont, and the E.coli DH5α with pSAM was a kind gift from Dr. Debbie
Yoder-Himes [96]. Basal media was purchased from Lifeline Cell Technology
(Frederick, MD). Sheep blood was purchased from Lampire Biological Laboratories
(Pipersville, PA). Nu-PAGE 4-12% Bis-Tris gels, PBS, RPMI-1640, DMEM, expression
plasmid pBAD kit, PCR supermix, EKmax and EKaway resin were purchased from
Invitrogen (Carlsbad, CA). LB broth and agar were purchased from BD Biosciences
(San Jose, CA). Anti-TLR2 (clone B4H2) and -4 (clone W7C11) antibodies, Quanti-Blue
NFκB assays, Hygro-Gold, blasticidin, Normocin, Zeocin, Ultra Pure LPS-EK, Human
TLR agonist kit were purchased from Invivogen (San Diego, CA). The anaerobic
chamber was bought from Coy Laboratories (Grass Lake Charter Township, MI).
Ampicillin, gentamicin, erythromycin, tetracycline, RIPA buffer, phosphatase and
proteinase inhibitor cocktails, arabinose, E.coli LPS, metronidazole, HEPES buffer,
sodium bicarbonate, sodium pyruvate, streptomycin and phallodin-TRITC stain were
purchased from Sigma-Aldrich (St. Louis, MO). Fetal bovine serum (FBS) was
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purchased from Atlanta Biologicals (Flowery Branch, GA). RNA purification kit was
purchased from 5-Prime (Gaithersburg, MD). All primers were ordered from
Biosynthesis Inc. (Lewiston, TX). ImageQuant LAS 4010, HiTrap Chelating HP column
was from GE Healthcare (Piscataway, NJ). Anti-p-p65, p-STAT4, p65, STAT4, β-actin
antibodies were purchased from Cell Signaling Technology (Beverly, MA). Anti-TLR2
and -TLR4 antibodies, siRNA TLR2, TLR4, p65, STAT4 and control were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Coomassie Blue stain and PVD
membrane were purchased from Bio-Rad Laboratories (Hercules, CA). Signaling
Pathway RT2 Profiler PCR arrays, SYBR Green Supermix with ROX were purchased
from Qiagen (Valencia, CA). Quanta cDNA synthesis mix from Quanta BioScience
(Gaithersburg, MD). IL-6, -8, IFNγ, IL-4, 12, TNF Elisas purchased from eBioscience
(San Diego, CA). GeneChip® 3’ IVT Express kit from Affymetrix (Santa Clara, CA).
NanoDrop Spectrophotometer ND-1000 from Thermo Scientifc (Wilmington, DE); (R)lisofylline was purchased from Cayman Chemical (Ann Arbor, MI). p65(Ser276) and
control peptide inhibitors were from Novus Biologicals (Littleton, CO). 4-D
Nucleofactor system, P3 primary transfection kit were purchased from Lonza (Rockland,
ME). CD14 I and II isolation kits were purchased from Miltenyi Biotec (San Diego, CA).
Lymphocyte separation medium (LSM), Triton X, 2-mercaptoethanol, 4-chambered
slides, Pro-Long Gold with DAPI stain were purchased from Fisher Scientific
(Pittsburgh, PA). Genomic DNA isolation kits were purchased from Promega (Madison,
WI). Fluoview FV1000 confocal system was purchased from Olympus (Center Valley,
PA). 1% paraformaldehyde solution was purchased from Electron Sciences Microscopy
(Hatfield, PA). ABI 7500 Real-Time PCR machine from Applied Biosystems,
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Supersignal West Pico Chemiluminescent substrate, Slide-A-Lyzer Dialysis Cassette,
10K MWCO, trypan blue and BCA Protein Assay kit were purchased from Thermo
Fisher Scientific (Rockford, IL).

Bacterial culture
Porphyromonas gingivalis strains W83 and 33277 were purchased from American Type
Culture Collection (Manassas, VA) and maintained in GAM broth. ∆ragB and
pTCBex2:ragBW83-carrying complemented P. gingivalis strains have been described
previously [74]. P. gingivalis strains were maintained in a Coy Laboratories anaerobic
chamber (80% N2, 10% H2, 10% CO2) at 37°C. E.coli TOP10 strain was maintained
aerobically in LB broth or LB agar plates at 37°C. Purity of bacterial cultures were
routinely screened by Gram stain.

Isolation and maintenance of human cells
Whole blood was isolated from healthy donors (≥ 18 years; ≥49.9 kg; free of any chronic
health problems; medication free; not pregnant) who provided written, informed consent
as approved by the Institutional Research Board at the University of Louisville. Buffy
coat was collected from an LSM gradient, washed in PBS (10mM, pH 7.2) and
monocytes were harvested from PBMCs using Milentyi CD14 magnetic beads. Viability
was routinely >98%, as assessed by trypan blue exclusion. Monocyte cells were
resuspended in RPMI 1640 containing penicillin (100 µg/ml), streptomycin (100 µg/ml)
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and 10% FBS. Monocytes were incubated at 37°C in 5% CO2 overnight prior to
stimulation.
THP-1 and THP-1 XBlue NF-kB/AP-1 SEAP reporter cell lines were maintained in
RPMI 1640 at 37°C 5% CO2. THP-1 XBlue cells were maintained with the addition of
Zeocin (200 µg/ml). HEK 293 (human embryonic kidney) cells were maintained in
DMEM with the addition of 10% FBS. HEK TLR 2/1, 2/6, 5 and null cells were
maintained with blasticidin (100 µg/ml) and Normocin (10 µg/ml), whileTLR4-MD2CD14 cells were maintained with blasticidin (100 µg/ml), Normocin (10 µg/ml) and
HygroGold (50 µg/ml). The TIGK (telomerase immortalized gingival keratinocytes) cell
line was a kind gift from Dr. Richard Lamont (University of Louisville). TIGKs were
maintained at 37°C 5% CO2 in basal media.

Production and purification of RagB
P. gingivalis W83 genomic DNA was purified using Promega Isolation kits and the ragB
gene was amplified by PCR (Fwd: CACCGAGCTTGACCGCGACCCC; Rev:
TATCGGCCAGTTCTTTATTAACTGCGG). The ragB product was gel purified on a
1% agarose gel and transformed into E.coli TOP10 strain using the pBAD202D TOPO
vector and TOPO expression kit, according to manufacturer’s instructions.
Transformants were plated on LB agar plates containing 50 µg/ml of kanamycin. PCR
was used to confirm uptake of ragB in selected colonies. E.coli containing ragB were
grown in LB broth and RagB expression was induced by arabinose. Cells were then
pelleted and lysed using CellLytic B buffer. The recombinant his-tagged RagB was
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collected by column purification (300nM imidazole fraction; HiTrap Chelating HP
column) and dialyzed using a Thermo Slide-A-Lyzer Cassette 10000 MWCO in PBS.
The dialyzed product was checked for purity by both SDS-PAGE gel (Figure 3) and mass
spectrometry, performed at the Mass Spectrometry Core Laboratory (University of
Louisville, KY). Lack of biologically meaningful protein contamination and other
pyrogens was confirmed by analysis of cytokine release from monocytes exposed to
denatured (SDS-treated) and heat-treated (boiled) RagB preparations (Figure 4).

RagB stimulation of IL-8 and NFκB in THP-1 cells
THP-1 cell lines were maintained in buffered RPMI 1640. The THP-1 and THP-1 XBlue
cell lines were plated in 96 well plates at ~500,000 cells per well. Cells were stimulated
with RagB (0, 1, and 10 µg/ml) and cell-free supernatant were harvested ~20 hour post
stimulation. THP-1 supernatant was use to analyze IL-8 production by ELISA
(eBioscience). THP-1 XBlue supernatant was used to measure NFκB production by the
use of Quanti-Blue assays (measured at 595nm wave length). THP-1 XBlue cells contain
a NFκB/AP-1 inducible reporter system which is used with Quanti-Blue assays to
measure NFκB/AP-1 activation via secreted embryonic alkaline phosphatase (SEAP)
reporter gene. E.coli LPS was used as a positive control for IL-8 and NFκB production.

RagB stimulation of cytokines from TLR-transfected HEK-293 cells
HEK cells were grown to ~80% confluence in 96 tissue culture plates. HEK transfected
hTLR2/1, 2/6, 4 and 5 cell lines were stimulated with their respective agonist
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(Pam3CSK4, FSL1, LPS and FLA-ST) and RagB (1 µg/ml). HEK null cells were used as
a negative control and stimulated with each TLR agonist and RagB, but did not induce
IL-8 production. Cell-free supernatants were collected 20 hours post stimulation. IL-8
production was measured by ELISA.

Quantification of RagB-induced cytokines in primary human monocytes
Isolated monocytes were plated in 96 well plates at 300,000 cells/well. Cells were
allowed to rest overnight at 37°C in 5% CO2 and then stimulated with Rag B (0.1, 1 or 10
µg/ml) or E.coli LPS (0.1 and 1 µg/ml). Cell free supernatants were harvested following
centrifugation 20 h post stimulation. ELISAs were used to measure IL-8, IL-6, IL-4, IL12, IL-10, IFNγ and TNF concentrations in the supernatants.

Identification of genes activated by RagB in a qRT-PCR TLR array
Primary human monocytes were stimulated with RagB (1 µg/ml) for four hours. RNA
was harvested with the 5-Prime RNA purification kit. cDNA was synthesized using
qScript cDNA synthesis kit and then run on a thermal cycler under the following
conditions: 22°C for 5 mins, 42°C for 30 mins, 85°C for 5 mins. One tenth of the firststrand reaction was used for the 96 well TLR Focused RT-PCR array plate, which allows
for analysis of message derived from 84 genes in the human TLR pathway. SYBR®
Green with ROX master mix was used as the fluorescence dye. An ABI 7500 RT-PCR
machine was used to read the plate. Each plate contained 5 housekeeping controls and
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the RagB stimulated plate was compared with the unstimulated control plate. 2-∆∆Ct value
was calculated.

Identification of genes activated by RagB in primary human monocytes by whole
genome arrays
Whole genome microarrays were used to determine the transcriptomic response of
primary human monocytes to RagB. Cells were plated in triplicate on 6 well plates at
4x106 cells/well. Cells were stimulated with 0, 1, or 10 µg/ml of RagB. RNA was
harvested by 5-Prime RNA isolation kit four hours post stimulation. Total RNA (100 ng)
was used per array. Following the manufacturer’s protocol: RNA was used to synthesize
first-strand cDNA (2hr incubation) and then synthesized to second-strand cDNA (1hr
incubation). In vitro transcription of aRNA (amplified RNA) that was biotin labeled with
an incubation period of 1 hr at 16°C and 10 mins at 60°C. aRNA was purified to remove
any salts or remaining free nucleotides. aRNA was then fragmented and incubated at
94°C for 35 mins. The fragmented product was hybridized to the GeneChip 3’ arrays.
Arrays were scanned using Command Console 3.2 (Affymetrix, St. Clara, CA). Each
group was measured in triplicate and the averages were taken. Files were imported into
Genomics Suite 6.6 (Partek Inc., St. Louis, MO) for summarization and background FDR
correction. One way ANOVA was used to compare the different treatments. Ingenuity
IPA software (Redwood City, CA) was used to filter genes with ±2 fold change, dosedependent response (10 >1 >0 g/ml RagB) and P value < 0.001. 243 differentially
regulated genes were identified. Ingenuity software was used to look at gene clusters and
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potential pathways. Microarrays were analyzed at the University of Louisville Genomics
Core facility.

qRT-PCR validation of RagB-regulated genes
Primary human monocytes were stimulated with 0 or 1 µg/ml of RagB. RNA was
harvested using the 5-Prime RNA purification kit four hours post stimulation. RNA
concentrations were measured by Nanodrop. cDNA was synthesized by qScript cDNA
synthesis kit (Quanta). RT-PCR cycle conditions were as follows: 2 mins at 50°C; 10
mins at 95°C; 15 sec at 95°C, 1 min at 55°C for 40 cycles. An ABI-7500 RT-PCR
machine was used to run the samples. Primer sequences (Table 1) were designed using
Primer-BLAST (www.nchi.nlm.nih.gov/tools/primer-blast).
Genes
IL-6
IL-1α
CCL20
IL-1β
IL-12β
IL-8
STAT-4
RagB
GAPDH

Forward Primer
TGCAATAACCACCCCTGACC
CAGGAGCTTGTCACCCCAAA
CAGTGCTGCTACTCCACCTC
CGCTCCGGGACTCACAGCAA
TCAAACCTGACCCACCCAAG
AGTCCTTGTTCCACTGTGCC
ATAAGAGGGAAGAGGACGCC
CACCGAGCTTGACCGCGACCCC
GCCGCATCTTCTTTTGCGTC

Reverse Primer
GTGCCCATGCTACATTTGCC
CATGGAGTGGGCCATAGCTT
TTGGACAAGTCCAGTGAGGC
GGTCCCTCCCAGGAAGACGGG
TCAGAACCTAACTGCAGGGC
CACAGCACTACCAACACAGC
ACATGCTAGCGCTCTCTCAG
TATCGGCCAGTTCTTTATTAACTGCGG
TCGCCCCACTTGATTTTGGA

Table 1. Primer sequences.
Primers used to verify select RagB-regulated monocyte genes identified by microarray
and to clone RagB.
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TLR specificity of RagB in primary human monocytes
Monocytes were plated in 96 well plates (300,000 cells/well) and allowed to rest
overnight. Monocytes were pre-treated for one hour with 1 µg/ml of anti-TLR2 or -4
blocking antibodies. Cells were then stimulated with RagB (1 µg/ml) and the TLR2 and
-4 agonists (HKLM at 108 cells/ml and LPS-EK at 1 µg/ml). Cell free supernatants were
harvested 20 hours post stimulation. ELISA was used to measure cytokine production.

Inhibition of STAT4 in RagB-stimulated primary human monocytes
Primary human monocytes were pre-treated with the STAT4 inhibitor, lisofylline (LSF),
for one hour. Cells were then stimulated with RagB (1 µg/ml) and cell-free supernatants
were harvested 20 hours post stimulation. Cytokine production was measured by ELISA.

Inhibition of NFκB (p65) in RagB-stimulated primary human monocytes
Primary human monocytes at 300,000 cells/well in 96 well plates were untreated or
exposed to combinations of RagB (1 µg/ml) or E. coli LPS (1 µg/ml) and a p65 or
negative control peptide inhibitor set (100 µM , 1 hr pre-treatment). Cell free
supernatants were harvested 20 hours post stimulation. Cytokine production was
measured by ELISA.
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TLR2, TLR4, p65 and STAT4 gene silencing
TLR2, TLR4, p65 and STAT4 genes were individually silenced in human monocytes by
siRNA transfection using the 4D-Nucleofactor system, according to the manufacturer’s
P3 primary cell protocol. A control siRNA scrambled sequence was used as a negative
control. Briefly, ~4 million cells were suspended in 100 µl transfection reagent in single
nucleocuvettes and 3 µl (30 pM) of siRNA added. Transfected monocytes were rested in
RPMI 1640 containing 10% FBS for 48 h at 37°C prior to stimulation with RagB and
other agonists, as described in the figure legends (9-12). Confirmation of gene silencing
was performed by Western blot analysis as shown in Figures 9, 11-12.

Colonization of epithelial cells by wildtype and ∆ragB P. gingivalis strains
TIGK cells were used as a model to study bacterial interactions with gingival epithelial
cells. TIGKs were plated in 12 well plates or 4-chambered glass slides until 80%
confluence was attained. TIGKs were maintained in basal media. P. gingivalis strains
(W83, ∆ragB, and complement) were used to infect the TIGKs at MOI of 10:1 for one
hour. Cells were then washed with PBS and basal media containing gentamicin (300
µg/ml) and metronidazole (200 µg/ml) was added for one hour. TIGK cells were then
lysed and lysates plated on GAM/blood agar or fixed with paraformaldehyde for confocal
analysis. CFUs were enumerated after seven days of anaerobic incubation. Unexposed
TIGKs were used as a negative control. Paraformaldehyde 4% was added to the
chambered wells for 20 minutes. Cells were washed with PBS and 0.2% Triton X-100
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was added for 10 mins. Wells were washed with PBS, and 10% horse serum was added
for 20 mins. Primary anti-P. gingivalis antibodies were added at 1:1000 for one hour.
Wells were then washed with PBS and the secondary antibody (anti-rabbit; 1:200) was
added for one hour. Wells were washed with PBS and phalloidin-TRITC (1:100) was
added for 40 minutes. Wells were then washed with PBS and coverslips were mounted
using Prolong Gold with DAPI and allowed to cure overnight. Slides were viewed using
Fluoview FV1000 confocal system at 60X magnification.

Induction of cytokines by wildtype and ∆ragB P. gingivalis in monocytes
Bacterial strains W83, ∆ragB, and complement were harvested at late log phase. Cells
were washed with PBS and fixed in 1% paraformaldehyde for one hour. Bacterial cells
were fixed prior to cell stimulation to control for the degradation of cytokines by bacterial
proteases. After fixation, cells were washed in PBS and used to stimulate primary
monocytes at a MOI of 10:1. Cell free supernatants were collected 20 hours post
stimulation for analysis by ELISA.

Preparation of RagB for crystallization
Purified RagB was digested with 0.1 unit of EKMax per 20 µg of protein. The reaction
mixture contained RagB, 10X EKMax Buffer and 0.1 unit of EKMax. The mixture was
incubated at 37°C for 16 hours. EKMax was removed using EK-Away resin. Briefly,
EK-Away resin was added to the mixture for two minutes and then pelleted. The
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supernatant was removed and the pellet resuspended in EK-Away Resin for another two
minutes. EK-Away 1X buffer was added and EK-Away Binding buffer was added to the
Enterokinase digestion mixture for 15 minutes and centrifuged. The supernatant was run
on SDS-PAGE gel and stained with Coomassie Blue to verify the correct size. Products
were then concentrated and sent for crystallization. Pymol generated the image, and the
analysis is currently being performed by our collaborator, Dr. Theodoros Goulas
(Structural Biology, Molecular Biology Institue of Barcelona, Spain).

Statistical analysis
All experiments were performed in triplicate unless otherwise stated. Data were analyzed
by student t-test or one-way ANOVA using GraphPad and Prism 4 software. P value less
than or equal to 0.05 was considered to represent statistically significant differences
between groups.

26

CHAPTER THREE: RESULTS

RagB production and purification

Purified, recombinant RagB protein was shown to be free of contaminants first by
using a NuPAGE gel stained with both Coomassie Blue and silver staining techniques
(Figure 3). Subsequently, the RagB band was extracted and sequenced using mass
spectrometry to confirm the presence of a single amino acid sequence homologous to that
expected for RagB. Primary human monocytes were used to test denatured RagB for
possible LPS, or other pyrogen, contamination by heat-denaturing the protein at 80°C for
20 mins or treating the protein with 10% SDS prior to stimulation. Heat-denatured and
SDS treated RagB did not elicit an IL-8 response in monocytes (Figure 4), further
verifying the recombinant protein to be free of contamination. IL-8 is a pro-inflammatory
cytokine that is involved in neutrophil recruitment and its promoter contains both an
NFᴋB and AP1 binding site that is inducible by LPS [97].
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Molecular
Weight
(kDa)

1

2

188 98 62 49 38 28 14 6 -

Figure 3. Purified RagB run on a NuPAGE® Novex® 4-12% Bis-Tris Gel and
stained with Coomassie Blue and silver stain.
Purified RagB was run on an NuPAGE 4-12% Bis-Tris gel to check from possible
contaminants. Coomassie Blue (1) and silver stains (2) were both conducted. Only one
band was visible on the gel using both stains.

28

5000

IL-8 (pg/ml)

4000

***
***

3000
2000
1000

U

ns
tim
ul
at
ed
R
ag
B
1
ug
/m
SD
l
LP
S
S
10
1
%
ug
&
/m
R
ag
l
B
B
oi
1
le
ug
d
/m
R
ag
l
B
1
ug
/m
l

0

Figure 4. Denatured RagB does not elicit a IL-8 response.
Monocytes were stimulated with RagB (1 µg/ml), LPS (1 µg/ml), SDS treated RagB or
boiled RagB. Cell free supernatants were harvested at 20 hrs post stimulation and IL-8
quantified by ELISA.
*** p<0.001 compared to the unstimulated control

RagB does not elicit a response in THP-1 and HEK transfected cell lines
Monocytic whole genome array data suggested that RagB induced multiple genes
known to be regulated by the transcription factor NFκB. THP-1 cells are monocytic
leukemic cells commonly used to study innate immunity while THP-1XBlue cells contain
a reporter plasmid controlled by an NFκB promoter system. Therefore, THP-1 cells were
challenged with RagB and E.coli LPS was used as a positive control for IL-8 cytokine
production. Cell free supernatants were harvested at 20 hours post stimulation. ELISA
used to measure the concentration of IL-8 in supernatants. RagB did not induce an IL-8
response in the THP-1 cell line (Figure 5).
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THP-1 XBlue cells were then used to determine if NFκB could be activated by
RagB. Quanti-Blue assays were performed on 20 h cell free supernatants in order to
measure the induction of NFκB. There was not a detectable level of NFκB induction in
THP-1 XBlue cells by RagB as shown in Figure 6. E.coli LPS was used as a positive
control for NFκB induction.
HEK cells are commonly used to identify TLR agonists since they are readily
transfected and do not naturally express surface TLRs. HEK hTLR cells stably
transfected with TLR-2/-1, TLR-2/-6, TLR-4, and TLR-5, as well as null transfected
HEK control cells were used to measure RagB induction of IL-8. Cells were
unstimulated or stimulated with RagB (1 µg/ml) or their respective classical agonists
(2/1, Pam3CSK4 at 1 µg/ml; 2/6, FSL1 at 1 µg/ml; 4, LPS at 1 µg/ml; 5, FLA-ST at 1
µg/ml). Cell free supernatants were collected 20 hours post stimulation. IL-8 cytokine
production was measured by ELISA. RagB induction of IL-8 was not detected in any of
the surface TLR transfected HEK cell lines, as shown in Figure 7.
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Figure 5. RagB does not induce an IL-8 response in THP-1 cells.
THP-1 cells were stimulated with RagB (1 µg/ml), LPS (0.1 and 1 µg/ml), and boiled
RagB. Cell free supernatants were harvested at 20 hrs post stimulation for ELISA.
*** p < 0.001 compared to unstimulated control.
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Figure 6. RagB does not induce NFκB in THP-1 XBlue cell line.
THP-1 XBlue cells were stimulated with RagB (1 and 10 µg/ml), LPS (0.1, 1 and 10
µg/ml). Cell free supernatant was harvested 20 hrs post stimulation. Quanti-Blue assays
were used to measure induction of NFκB by secreted alkaline embryonic phosphatase.
*** p < 0.001 compared to unstimulated control.
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Figure 7. RagB does not signal through surface exposed TLRs in HEK cell lines.
HEK 293 cells transfected with (A) hTLR 2/1, (B) hTLR 2/6, (C) hTLR 4 and (D) hTLR
5. Cells were stimulated with RagB (1µg/ml) and TLR respective agonist. Cell free
supernatant was harvested 20 hrs post stimulation and measured by ELISA.
*** p < 0.001 compared to unstimulated control.
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RagB induces pro-inflammatory cytokines in primary human monocytes

To measure cytokine levels, primary monocytes were stimulated with RagB (0.1,
1 or 10 µg/ml) and E.coli LPS (0.1 or 1 µg/ml) for 20 hours. Cell free supernatant was
harvested for ELISA. RagB induced a significant, dose-related increase in the IL-8
response, compared to unstimulated controls (Figure 8). Similar results were obtained
for both IL-6 and TNF (Figure 8). This confirms RagB promotes production of proinflammatory cytokines in primary human monocytes. RagB was also degraded by
boiling and SDS digestion. Cells stimulated with degraded RagB did not induce an
inflammatory response (Figure 4).
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Figure 8. RagB induces pro-inflammatory cytokines in primary innate cells.
Primary human monocytes were untreated or treated with E. coli LPS (0.1, or 1 µg/ml) or
with RagB (0.1, 1, or 10 µg/ml).(A) IL-8, (B) IL-6 and (C) TNF (D) IFNγ concentrations
in 20 hr cell-free supernatants were determined by ELISA. No, or minimal, protein signal
was observed for IL-10 or IL-12.
**p<0.01, ***p<0.001, compared to unstimulated control.
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RagB induces multiple pro-inflammatory genes in TLR-focused arrays

In order to understand the mechanisms of pro-inflammatory cytokine induction by
RegB, we initially used focused arrays to screen for RagB activation of 84 major TLR
pathway-related genes. Primary human monocytes were stimulated with 0 or 1 µg/ml
RagB and total RNA was harvested four hours post stimulation. Additionally, LPS 1
µg/ml was used as a positive control. cDNA was synthesized and used in RT-PCRbased, TLR-focused arrays. Each set of TLR genes were compared to 5 housekeeping
genes and the 2 -ΔΔct method [98] was used to compare unstimulated vs stimulated groups.
The pro-inflammatory genes encoding IL-1β, IL-8, IL-1, CCL2, and IL-6 were each
shown to be upregulated in cells stimulated with RagB as shown in Table 2. The genes
CCL2, CLEC4E, HSPA1A, IL-1α, IL-8, NFᴋB1A, PTGS2 and REL were shown to be
upregulated in cells stimulated with LPS as shown in Table 3.
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Gene

Description

Fold change

IL-1β

Interleukin 1, beta

83.4

IL-8

Interleukin 8

35.3

IL-1α

Interleukin 1, alpha

18.7

CCL2

Chemokine (C-C motif) ligand 2

7.1

IL-6

Interleukin 6

5.8

Table 2. RagB induces multiple TLR-related genes in primary human monocytes.
RNA was harvested 4 hr post treatment and reverse transcribed for hTLR RT-PCR array.
The 2 -ΔΔct method was used to determine significant differences from the control
(unstimulated) group. 5 of the 84 genes in the TLR Signaling Pathway RT² Profiler PCR
array were upregulated, as noted above.

Gene

Description

Fold Change

CCL2

Chemokine (C-C motif) ligand 2

14.0

CLEC4E

Colony stimulating factor 2 (granulocyte-macrophage)

19.1

HSPA1A

Heat shock 70kDa protein 1A

2.6

IL-1α

Interleukin 1, alpha

80.2

IL-8

Interleukin 8

196.2

NFKBIα

Nuclear factor of Kappa light polypeptide gene chancer in B-cells
inhibitor, alpha

19.4

PTGS2

Prostaglandin-endoperoxide synthase 2

290.0

REL

V-rel reticuloendotheliosis viral oncogene homolog

17.6

Table 3. LPS induces multiple TLR-related genes in primary human monocytes.
RNA was harvested 4 hr post treatment and reverse transcribed for hTLR RT-PCR array.
The 2 -ΔΔct method was used to determine significant differences from the control
(unstimulated) group. 8 of the 84 genes in the TLR Signaling Pathway RT² Profiler PCR
array were upregulated, as noted above
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RagB induces multiple pro-inflammatory genes in a dose-dependent manner in
whole genomic microarrays

Focused TLR arrays identified RagB-induced pro-inflammatory mediators, but
did not provide any insights on the underlying mechanisms involved in cytokine
induction. Therefore, we next determined the whole genomic response of primary human
monocytes to RagB stimulation. Monocytes were stimulated with 0, 1 or 10 µg/ml of
RagB for four hours and total RNA was harvested. The results were filtered by
Bonferroni correction and genes were considered differentially regulated if there was ±2
fold change in message level at each dosage when compared to the unstimulated control,
and a dose-related response (i.e. the induced signal at 10 g/ml was > 1g/ml which was
> 0 g/ml) that was statistically significant ( p <0.001). The filtered list contained 243
genes, of which selected upregulated genes are presented in Table 4. Genes selected are
implemented in NFᴋB/STAT pathways suggesting a possible signaling mechanism of
RagB-induction. These selected genes were verified by real-time PCR, again, as shown in
Table 4. Similar results were obtained in the RT-PCR array (Table 2) for IL-6, IL-8 and
IL-1β. STAT4 was shown to be the most upregulated transcription regulator,
coincidently, is connected to many of the most upregulated genes as shown in Figure 9.
This suggests RagB promotes a strong pro-inflammatory signal that could activate
transcription through the STAT4 pathway.
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Fold Change
Microarray

RT-PCR

Gene

1vs0

10vs0

1vs0

IL-6

612

800

153

CCL20

380

449

34

IL-1β

295

311

113

IL-12β

146

765

2.8

STAT4

35

51

6

TNF

24

32

9

IL-8

7.3

7.5

2.7

Table 4. RagB induces multiple pro-inflammatory genes in dose-related manner.
Primary human monocytes were stimulated with 0, 1 or 10 μg/ml of RagB. RNA was
harvested 4 hr post-stimulation and used for microarray analysis. 243 genes were
differentially regulated, as determined by Bonferroni correct p-value, and also exhibited a
dose-related response (10 > 1 > 0 μg/ml RagB). Selected genes were verified by RTPCR. RT-PCR was analyzed by 2-ΔΔCt method.
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Figure 9. Pathway analysis of the top differently regulated genes in relationship with
STAT4.
Ingenuity pathway analysis displaying genes identified by microarray analysis to be
associated with the transcription regulator, STAT4. Genes in red are upregulated, and
genes in green are down regulated. Solid lines indicate direct interactions between genes,
and dashed likes indicate indirect interaction between genes.
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RagB induction of IL-8 is TLR2-dependent

Toll-like receptors (TLRs) play a major role in microbial recognition and innate
immune signaling. Previous studies have shown TLRs to be essential in P. gingivalis
induced infections [65, 99, 100]. TLR2 was shown to be required for P. gingivalis
induced oral bone loss using TLR2-knockout mice[101]. To investigate the potential
engagement of TLR-2 by RagB, anti-hTLR2 antibodies were used to block binding of
TLR-2 agonists to primary human monocytes. Anti-TLR2 and IgA2 (isotype control)
antibodies were added at 1 µg/ml for one hour prior to RagB stimulation. RagB (1
µg/ml) was used to stimulate the cells and cell free-supernatants were harvested 20 hours
post stimulation. The classic TLR-2 agonist, Pam3CSK4, was used as a positive control.
Cells exposed to anti-TLR2 antibodies then RagB showed a significant decrease in IL-8
production when compared with cells stimulated with RagB alone (Figure 10). IgA2
isotype control did not influence RagB-induced IL-8 production. This suggests RagB
induces IL-8 production at least partially through TLR2.
To confirm TLR-2 engagement by RagB, a second experimental approach was
adopted, i.e., gene silencing. Primary human monocytes were transfected with 30 pM of
control (non-targeting negative control) or TLR-2-specific siRNA. Cells were allowed to
rest for 48 hours and then stimulated with RagB (1 µg/ml) for 4 or 20 hours. Total
protein was harvested at 4 hours post stimulation and cell free supernatant was harvested
at 20 hours post stimulation. Successful TLR-2 silencing was confirmed by Western blot
and the subsequent reduction of IL-8 induction upon RagB stimulation in silenced cells is
shown in Figure 10.
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Figure 10. RagB induction of IL-8 is TLR2-dependent.
Primary human monocytes were untreated or exposed to combinations of RagB (1
μg/ml); the TLR2 agonist, Pam3CSK4 (1 μg/ml), anti-TLR2 (1 μg/ml, 1 hr pretreatment) and control (IgA2, 1μg/ml, 1 hr pre-treatment) antibodies. In an alternative
strategy, TLR2 gene silencing was performed, as described in the text. (A) IL-8
concentrations in 20 hr cell-free supernatants were determined by ELISA. TLR2
knockdown was confirmed by (B) Western blot and (C) densitometry. (D) Inhibition of
RagB induced IL-8 upon TLR2 gene silencing was determined by ELISA.
*p<0.05, **p<0.01, ***p<0.001. (B) and (C) represent typical data.
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RagB induction of IL-8 is TLR4-dependent

To investigate the potential engagement of TLR4 in the innate response to RagB,
anti-TLR4 antibodies were used to block TLR4 agonists to primary human monocytes.
Anti-TLR4 and IgG1 (isotype control) antibodies were added at 1 µg/ml for one hour
prior to RagB stimulation. The classic TLR4 agonist, LPS, was used as a positive
control. Cells exposed to anti-TLR4 antibodies then RagB showed a significant decrease
in IL-8 production when compared with cells stimulated with RagB alone (Figure 11)
IgG1 isotype control did not influence RagB-induced IL-8 production. This suggests
RagB induction of IL-8 is at least partially though TLR4.
We attempted to confirm TLR4 engagement by RagB using a second
experimental approach, i.e., gene silencing, but were unsuccessful after multiple
attempts.
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Figure 11. RagB induction of IL-8 is TLR4-dependent.
Primary human monocytes were untreated or exposed to combinations of RagB (1
μg/ml); the TLR4 agonist, LPS (1 μg/ml), anti-TLR4 (1 μg/ml, 1 hr pre- treatment) and
control (IgG1, 1μg/ml, 1 hr pre-treatment) antibodies. IL-8 concentrations in 20 hr cellfree supernatants were determined by ELISA.
***p<0.001

RagB induction of IL-8 is STAT4-dependent

Genomic microrarrays identified STAT4 as a potentially important transcription
regulator in the RagB-induced innate response. STAT4 has previously been shown to
play a critical role in inflammation in monocytic cells [102]. Thus, the STAT4 inhibitor,
LSF, was used to pharmaceutically inhibit STAT4 in cells stimulated with RagB.
Primary human monocytes were pre-treated with LSF (25 or 100 µM) for one hour. Cells
were then stimulated with RagB (1 µg/ml). Cell free supernatants were harvested 20
hours post infection for detection of IL-8 by ELISA. LSF significantly suppressed the
induction of IL-8 by RagB.
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In addition to pharmaceutical inhibition of STAT4, gene silencing by siRNA was
also used to investigate RagB signaling. Primary human monocytes were transfected
with 30 pM of control or STAT4-specific siRNA. Cells were allowed to rest for 48 hours
and then stimulated with RagB (1 µg/ml) for 4 and 20 hours. Total protein was harvested
at 4 hours post stimulation and cell free supernatant was harvested at 20 hours post
stimulation. There was a decrease in total STAT4 protein at 4 hours and a significant
decrease in IL-8 production in cells stimulated with RagB transfected with STAT4
siRNA (Figure 12). This strongly suggests RagB signals though STAT4 in the context
of IL-8 induction.
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Figure 12. RagB-induction of IL-8 is STAT-dependent.
Primary human monocytes were untreated or exposed to combinations of RagB (1 μg/ml)
and the STAT4 inhibitor, LSF (25 and 100 μM, 1 hr pre- treatment). STAT4 gene
silencing was performed, as described in the text. (A) IL-8 concentrations in 20 hr cellfree supernatants were determined by ELISA. STAT4 knockdown was confirmed by (B)
Western blot and (C) densitometry. (D) Inhibition of RagB induced IL-8 on STAT4 gene
silencing was determined by ELISA.
***p<0.001. (B) and (C) represent typical data.
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RagB induction of IL-8 is NF-kB (p65)-dependent

The NFκB transcriptional pathway is the best defined major pathway controlling
pro-inflammatory responses to pathogens and MAMPs. An NFκB p65 (Ser276) inhibitor
peptide was used to block phosphorylation of the NFκB complex in cells stimulated with
RagB. The peptide inhibitor acts as a p65 decoy through the phosphorylation of the
Ser276 site located on the peptide. Primary human monocytes were pre-treated with p65
or control peptide one hour prior to stimulation with RagB (1 µg/ml) or E.coli LPS (1
µg/ml). LPS is a typical TLR4 agonist thus was used as a positive control for NFᴋB
induction. Cell free supernatants were harvested 20 hours post stimulation and their IL-8
content quantified by ELISA. The IL-8 response in RagB stimulated monocytes was not
influenced by a negative control peptide. The p65 peptide inhibitor, on the other hand,
significantly suppressed the induction of IL-8 by RagB.
Again, a gene silencing approach was taken in order to confirm the importance of
p65 in the inflammatory response of primary innate cells to RagB. Primary human
monocytes were transfected with 30 pM of control or p65-specific siRNA. Cells were
allowed to rest for 48 hours and then stimulated with RagB (1 µg/ml) for 4 or 20 hours.
Total protein was harvested at 4 hours post stimulation and cell free supernatant was
harvested at 20 hours post stimulation. There was a decrease in total p65 protein at 4
hours and a significant decrease in IL-8 production in cells stimulated with RagB
transfected with p65 siRNA (Figure 13). This strongly suggests RagB signals though
NFᴋB in the context of IL-8 induction.
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Figure 13. RagB-induction of IL-8 is NFκB (p65)-dependent.
Primary human monocytes were untreated or exposed to combinations of RagB (1 μg/ml)
and a p65 peptide inhibitor set (100μM, 1 hr pre- treatment). p65 gene silencing was
performed, as described in the text. (A) IL-8 concentrations in 20 hr cell-free
supernatants were determined by ELISA. p65 knockdown was confirmed by (B) Western
blot and (C) densitometry. (D) Inhibition of RagB induced IL-8 on p65 gene silencing
was determined by ELISA.
***p<0.001. (B) and (C) represent typical data.
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RagB induces phosphorylation of STAT4 and p65

The phosphorylation of proteins is essential in the regulation of biological
pathways including the NFᴋB (p65) and STAT4 proteins, which become activated once
phosphorylated and are able to travel to the nucleus for transcription [103, 104]. To
confirm activation of STAT4 and p65, total protein was harvested at 0, 15, 30, 60, 90,
120, and 180 minutes post-RagB (1 µg/ml) stimulation of primary human monocytes.
Western blot analysis showed p65 activation as early as 15 minutes post-RagB
stimulation with STAT4 phosphorylation occurring shortly after p65 activation (Figure
14). This suggests NFᴋB may potentially be activating STAT4 once it becomes
phosphorylated. A previous study has shown STAT4 to contain NFᴋB binding sites and
is capable of being activated by NFᴋB [105].

Figure 14. RagB induces the phosphorylation of STAT4 and p65.
Primary human monocytes were treated with 1 μg/ml RagB and total proteins were
harvested. Western blot of proteins harvested at 0, 15, 30, 60, 90, 120, and 180 mins
using STAT4 and p65 phosphorylated antibodies. β-actin was used as a loading control.
Results represent typical data.
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ΔragB mutant induces weaker inflammatory response than wild type P. gingivalis

The recombinant form of the RagB protein was shown to induce a strong proinflammatory response in primary human monocytes. However, it is also important to
establish the inflammatory potential of RagB in the context of the whole bacterium. W83
wild type, W83 ΔragB and ragB complemented strains were used to stimulate primary
monocytes. A recent study has shown live P. gingivalis secretion of gingipains to
degrade IL-8 cytokines [106], thus, bacterial cells were fixed in 1% paraformaldehyde for
one hour prior to stimulation to control for cytokine degrading due to gingipains.
Monocytes were challenged with bacteria (MOI 1:10) and cell-free supernatants were
harvested 20 hours post-stimulation. ΔragB mutants displayed a significant reduction in
cytokine response in the context of IL-8 in comparison to both wild type and ragB
complemented bacteria. Similar results were obtained for TNF and IL-6 (Figure 15).
Thus, similarly to purified, recombinant RagB, ragB appears to induce a robust proinflammatory response in monocytes in the context of the whole bacterium.
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Figure 15. ΔragB mutant induces weaker inflammatory response than wild type
strain.
Primary monocytes were stimulated with MOI 10:1 fixed P. gingivalis strains for 20 h
and cell free supernatant was collected. (A) IL-8, (B) IL-6 and (C) TNF concentrations
determined by ELISA.
**p<0.01,***p<0.001 compared to wild type strain.
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ΔragB mutants are unable to colonize TIGKs

Previous studies have suggested ragB to be important in P. gingivalis virulence,
particularly, epithelial cell invasion. To investigate the contribution of ragB to cell
invasion, we challenged an oral epithelial cell line (TIGK cells) with wild type, ΔragB
and complemented ragB strains. TIGKs were challenged with bacteria for 1 hour then
antibiotics were added to kill any remaining extracellular bacteria. After one hour, cells
were lysed and plated on GAM/blood agar plates for CFU enumeration. The ΔragB and
complemented CFU counts were significantly lower than the parental, wild type strain
(Figure 16). This provides evidence that ragB may play a role in the colonization of host
cells.
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Figure 16. ΔragB mutant exhibits lower colonization rate than wild type in TIGKs.
TIGKs were plated in 12 well plate. TIGK cells were unexposed or exposed to W83,
ΔragB and complemented strains for 1 hr at MOI 10:1. Cells were washed with PBS and
media was replaced with basal media containing gentamicin (300 µg/ml) and
metronidazole (200 µg/ml) for 1 hr. Cells were then lysed and supernatants were plated
on GAM/blood agar and incubated anaerobically at 37°C for 7 days. CFU were then
counted.
***p<0.001
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Confocal microscope analysis of P. gingivalis ΔragB inability to colonize TIGKs

To investigate the importance of ragB in epithelial cell colonization, TIGK cells
were uninfected or challenged with wild type and ΔragB strains at an MOI of 10:1 for
one hour. Antibiotics were used to kill any remaining extracellular bacteria. Cells were
then fixed and stained for confocal analysis. The wildtype strain was able to invade, but
the ΔragB strain did not appear to be able to colonize the TIGKs (Figure 17). This
combined with colonization assay CFU counts strongly suggests ragB plays a role in the
colonization of TIGKs.
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Figure 17. ragB appears to play a role in invasion of TIGK cell line.
TIGK cells were (A) unexposed or exposed to (B) W83 and (C) ΔragB strains for 1 hr at
MOI 10:1. Cells were washed with PBS and media was replaced with basal media
containing gentamicin (300 µg/ml) and metronidazole (200 µg/ml) for 1 hr. Cells were
then fixed in 4% paraformaldehyde and stained for confocal. Blue is the DAPI stained
nucleus, red is stained actin, and green represents P. gingivalis.
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RagB Structure

RagB was expressed in E.coli TOP10 strain and purified under non-denaturing
conditions as previously stated. Thioredoxin is a common tag used in the production of
recombinant proteins with no known inflammatory properties [107]. However, for
crystallization purposes, it was important to remove the thioredoxin tag, which was
achieved by EKMax digestion. Figure 18 represents a 3-D image of the RagB crystal
structure using Pymol image software. Identification of active sites and other structure
analysis are currently under investigation.

Figure 18. RagB crystal structure. Crystal structure of the 55kDa outer membrane
protein, RagB, from P. gingivalis W83. Stereo ribbon diagram of RagB monomer
generated in Pymol; color-coded from N-terminus (blue) to the C-terminus (red)
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CHAPTER FOUR: DISCUSSION

P. gingivalis elicits a strong pro-inflammatory response which is thought to
represent a critical driving force in the progression of periodontal diseases. This
inflammation-driven destruction of host cells and tissues enable P. gingivalis to acquire
essential nutrients [108]. The P. gingivalis armory includes multiple factors that
manipulate the innate response, including gingipains, LPS, capsule production, fimbrial
proteins and the rag locus. RagB is a predominant, highly antigenic, environmentally
regulated, surface-exposed outer membrane protein of P. gingivalis. Environmental
stimuli also play a role in RagB expression. Tobacco smoke, a major risk factor for
periodontitis, suppresses capsule generation, enhances fimbrial protein expression and
augments biofilm formation in P. gingivalis [109], which may help to explain the
increased severity of periodontal diseases observed in smokers. Tobacco smoke is also a
potent inducer of RagB expression [109]. RagB expression is also temperature regulated,
with increased temperature a hallmark of plaque-induced periodontal inflammation [110].
RagB is homologous to the SusD group of polysaccharide uptake proteins of other
Bacteroidetes species, including NanU found in Bacteroides fragilis[111]. A Rag
homologue in Bacteroidetes caccae (OmpW) has been associated with inflammatory
bowel disease [112].

Subcutaneous inoculation of ragB mutant P. gingivalis into mice

resulted in attenuated virulence, assessed by soft tissue lesion size and survival [74, 75].
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Furthermore, the ability of RagB mutants to invade transformed epithelial-like cells is
curtailed [113]. RagB has also been shown to be associated with more severe forms of
disease in patients with periodontitis [70]. Despite such data implicating RagB as an
important immunomodulatory molecule, RagB-innate interactions have not been
previously examined mechanistically.
We were unable to induce IL-8 or NFᴋB in the THP-1 cell line with RagB. A
recent study concluded THP-1 cells exhibit different inflammatory expression levels than
primary human monocytes [114]. In this study, both cell types were stimulated with the
TLR4 agonist, LPS, which induced a minimal IL-8 response in THP-1 cells compared to
the monocyte expression. Also, IL-6 and IL-10 were not detected in THP-1 cells in
response to LPS. This may help to explain why we were unable to detect a inflammatory
response to RagB in THP-1 cells. Consequently, we were unable to induce an IL-8
response in TLR transfected HEK cells with RagB stimulation. One possible explanation
is the cell line is possibly missing an adapter molecule required for TLR/RagB
interactions. Therefore, we decided to use a more relevant cell model by using primary
innate cells for our investigations.
We show, for the first time, that RagB is a strong TLR agonist. As has been
reported for P. gingivalis derived LPS [115], RagB can engage both TLR2 and -4,
resulting in the induction of multiple pro-inflammatory cytokines including IL-6, IL-8
and TNF. This innate activation occurs, unusually, in a STAT4-dependent manner, as
determined using the pharmaceutical inhibitor, lisofylline, and gene silencing.
STAT4 is best known as an important transcription factor in non-antigenic
induction of cytokines in T-cells, type I interferon signaling, and IL-12-mediated
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development of Th1 cells from naïve CD4+ T cells [105, 116, 117]. More recently,
STAT4 has been shown to be expressed in other immune cells, particularly activated
monocytic cells [105]. STAT4 has been suggested as a potential therapeutic target for
various inflammatory diseases, including shock [100, 105, 118, 119]. Whole microbial
induction of STAT4 expression in innate cells has been established for Mycobacterium
tuberculosis and Candida albicans [105]. STAT4 has been reported to bind to MyD88,
the TLR-associated signal transducer, and also to the TNF promoter [120]. STAT4 has
been shown to result in the induction of IFNγ (interferon gamma) in certain cell types and
has been shown to be inducible by LPS [121, 122]. IFNγ is a major immune regulator
involved in many phases of the immune response including TH1 differentiation and
enhancement of antibody production in response to foreign antigens [123, 124]. Indeed,
microbial STAT4 activation has been shown to result in the induction of classic NFκBregulated cytokines, but not IFNɣ, in conventional dendritic cells [105]. Similarly, we
could not detect an IFNɣ signal in RagB exposed monocytic cells, despite STAT4
upregulation (Figure 8). It has been reported that the activation of STAT4 by IL-12,
well-defined in T cells, does not occur in innate cells of monocytic lineage [118]. Indeed
monocytic cell expression of IL-12 receptors is a scientific disagreement. Grohmann et
al. show macrophages express the surface receptor IL-12 [125], but Remoli et al. were
unable to induce IL-12 protein expression [105]. The STAT4 promoter contains an
NFκB binding site -969/-959 bp upstream from the transcriptional start site that binds
p65/p50 and p50/p50 dimers [105]. In addition to STAT4-dependence, RagB induction
of pro-inflammatory cytokines requires NFκB (p65), as determined using both
pharmaceutical and siRNA approaches. NFκB is the major transcriptional regulator
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associated with TLR activation. Thus, RagB activation of the innate response in human
monocytes exhibits both classical and atypical elements of the TLR signaling pathways.
Clearly, recombinant RagB may differ from the natural protein, particularly as it
is not anchored in the cell membrane. However, the advantage of using recombinant
technology has been long established. Recombinant proteins can be readily purified in
large amounts and be free of accessory proteins (such as RagA). It is important to note
RagA and RagB are thought to form a protein-protein complex, raising the question of
the inflammatory potential to the combined Rag complex.
With this in mind, we also examined cytokine (IL-6, IL-8 and TNF) production in
monocytes exposed to WT, ΔragB and complemented P. gingivalis strains. These data
support a pro-inflammatory role for RagB in the context of the whole bacterium, similar
to the recombinant protein. Bacterial cells were pre-fixed in 1% paraformaldehyde, thus
controlling for cytokine destruction by secreted gingipains. Paraformaldehyde has been
proven to effectively preserve morphology and surface ultra-structure in bacterial cells
[126].
TIGKs were used to determine if RagB plays a role in epithelial cell colonization.
TIGKs are a recently developed immortalized epithelial cell line used to study oral
bacteria interactions with host gingival cells [127]. It has previously been suggested that
the rag locus plays a role in cell invasion based on hybridization arrays comparing
invasive and non-invasive strains [113]. Using CFU counts and visualization by
confocal, we showed the ∆ragB mutant strain was unable to colonize TIGK cells.
However, the complemented mutant was unable to restore colonization capability similar
to wildtype in TIGKs. We were able to show the complement strain restore
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inflammatory responses to wildtype levels, however, the bacteria were fixed in paraformaldehyde prior to infection. This may be dueto the large size of the complementing
vector, or the strain may have become weakened or impaired. P. gingivalis strains do not
naturally contain plasmids, thus the plasmid may have impaired intracellular survival.
An alternative strategy to complementation would be to reinsert the ragB gene back into
the ∆ragB mutant strain. Established immunomodulatory virulence factors of P.
gingivalis include LPS, fimbrial proteins (FimA and Mfa1), capsular polysaccharides and
gingipains [45, 51, 128]. It appears that RagB, which induces multiple pro-inflammatory
cytokines in a dose-related, TLR-, STAT4- and p65- dependent manner, may now be
added to this list, at least as ascertained using recombinant protein and rag-specific
mutants.
RagB, is assumed to facilitate polysaccharide, or other nutrient transport, along
with RagA. The rag locus is thought to facilitate transport through the periplasmic
spanning protein, TonB. RagA is a membrane associated protein that forms a pore like
structure in the outer membrane and RagB is an exposed outer membrane protein. It has
been previously proposed that rag may aid in ferrous iron transport [68]. Additionally, a
study using rag mutants demonstrated a delayed growth rate when compared to wildtype,
but similar growth rates with digested media suggesting rag may aid in the transport of
larger peptides [74]. rag locus homologs, the sus system found in Bacteroides sp. are
involved in sugar uptake [129]. That being said, it is still unclear of the molecules
transported by the rag locus of P. gingivalis.
Our initial structural analyses of RagB are suggestive of a disaccharide-binding
protein (Figure 17). As P. gingivalis is considered asaccharolytic, however, the
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physiological relevance of sugar uptake is not immediately transparent, but is likely to be
important in, for example, capsule generation or other non-ATP generating metabolic
processes. Additionally, RagB, as a promoter of inflammation, is likely to contribute to
the availability of protein, required by P. gingivalis as a carbon source.
Chronic periodontitis is a major health problem worldwide and is caused by
persistent stimulation of the innate response to oral pathogens. Periodontitis is also
associated with other diseases such as diabetes, rheumatoid arthritis, and cardiovascular
disease. Inflammation occurs when immune cells recognize foreign antigens by PPRs.
P. gingivalis, a causative agent in periodontitis, uses multiple virulence factors to
establish infection and persist within the host. Dental biofilms typically develop between
the tooth and oral epithelium that serve as protective reservoirs for bacteria against the
innate immune response. RagB, a major virulence factor of P. gingivalis, is commonly
associated with severe periodontitis. This thesis investigates the inflammatory potential
of RagB and the mechanisms involved. Studies have shown RagB to be the most
immune dominant outer membrane antigen of P. gingivalis and have associated it with
periradicular lesions. We show RagB elicits a pro-inflammatory response in primary
monocytes. This finding may aid in the understanding of the inflammatory response to P.
gingivalis in periodontal diseases. With a clear need for better therapeutics and
preventive strategies for periodontal disease, RagB would serve as a good candidate for
further exploration based on inflammatory properties shown herein.
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CHAPTER FIVE: THERAPEUTIC IMPLICATIONS

Ongoing Investigations:
Studies involving rag mutants and using the Baker bone loss model are currently
ongoing in the Scott lab [130]. The Baker model will be used to measure ragA and ragB
contribution to bone loss in context of whole bacterium. Bacterial burden of P. gingivalis
strains in the oral cavity and blood will also be examined. Neutrophil recruitment will
also be measured in the oral gingival tissues.
Tn Seq library of P. gingivalis has been constructed (JH). The 80,000 colony
mutant library pool will be used to identify genes as essential in cigarette smoke exposed
(CSE) media, colonization of epithelial cell line and murine abscess models. Highthroughput sequencing has been conducted and data analysis is currently underway.

Pharmacological approaches
Host inflammatory pathways have been used as targets for controlling periodontal
diseases. Adamowicz et al showed that systemic administration of a GSK3-specific
inhibitor, SB216763, led to the suppression of P. gingivalis-induced pro-inflammatory
cytokine production and reduced recruitment of neutrophils, while abolishing periodontal
bone loss in mice [131]. Following activation of TLRs in monocytes and PMBCs,
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GSK3β (glycogen synthase kinase-3) has been shown to be necessary for full stimulation
of pro-inflammatory cytokines, including IL-6, IL-1β and TNF [132]. We show that
RagB signals through TLR2 and -4 and induced pro-inflammatory cytokines in a STAT4and p65-dependent manner.
Therefore, we attempted to use a similar approach of targeting the host
inflammatory pathway, in vitro. The STAT4 inhibitor, lisofylline, has been shown to
reduce diabetes by controlling IL-12 induction of STAT4 in mice [15]. We show
lisofylline reduces the inflammatory response to RagB in vitro, and thus, may have
potential in controlling periodontitis in an in vivo model. By identifying inflammatory
pathways induced by P. gingivalis, new therapeutic targets can be developed.
A potential downside of this approach, targeting host inflammatory pathways, is the
suppression of the innate immune response. Targeting the host’s immune response is not
specific to one particular pathogen, thus, can potentially promote increase susceptibility
to infection by immune suppression. Alternatively, a more relevant approach would be
to target antigen specific epitopes of pathogens. RagB could potentially serve as target
for P. gingivalis infections based on its location on the outer membrane surface, host
recognition and specificity to P. gingivalis.
Implications of a ragB vaccine:
The potential of ragB as a vaccine candidate has been examined by Zheng et.al
[76]. A ragB-linked DNA vaccine in mice increased antibody production, reduced lesion
size and increased resistance to P. gingivalis infection. DNA vaccines are eukaryotic
non-replicating expression vectors that can be injected directly into cells, followed by
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expression of the encoded gene which leads to immune activation against the specific
antigen being produced [133]. Our data further support targeting RagB as a potential
therapeutic agent with which to control P. gingivalis-induced inflammatory disease,
based on surface availability and pro-inflammatory properties. P. gingvalis is a keystone
pathogen that causes dysbiosis in the oral microbiome, thus, eliminating P. gingivalis
could allow the microbiome to restore homeostasis.
However, it must be remembered that there is considerable antigenic variation at
the rag locus, with at least four non-cross reactive RagB proteins identified [134]. It is
possible, then, that RagB produced by different P. gingivalis strains may have altered
inflammatory activities and, thus, exhibit differing virulence potential. Indeed, the highly
virulent P. gingivalis lab strains W83 (used herein) and W50 each carry rag1, which has
been clinically associated with deep periodontal pockets, along with 26% of 168 isolates.
The less pathogenic strain, ATCC 33277, carries rag4, along with 14% of isolates, which
cross reacts poorly with W83-specific RagB antibodies [70, 73, 134]. The nucleotide
sequences of ragA and ragB of 33277 and W83 are 72% and 59% [74]. This may be
important in the drive to develop RagB-based vaccines for periodontal disease prevention
[76]. Fortunately, DNA vaccines can be constructed to encode multiple genes on one
expression plasmid [135].
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Crystal structure analysis
The crystal structure of the recombinant RagB is solved and currently being
analyzed. The RagB homologs, NanU and SusD, crystal structures have previously been
published [111, 129]. RagB is surface exposed which provides a potential therapeutic
target. The solved structure analysis could potentially be used to identify proteins or
carbohydrates, active sites able to bind sugars for transport and additional host cell
receptors capable of binding to RagB. The solved structure may aid in the development
of therapeutics towards P. gingivalis associated diseases such as inhibitory peptides to
block TLR-engagement of RagB or potentially to block attachment to host cells. Though
the exact role/s RagB contributes to bacterial survival in vivo has yet to be eluted, RagB
does appear to play a major role in virulence and could serve as a potential therapeutic
agent.

Viruelnce models of P. gingivalisIt has been shown that P. gingivalis has the
ability to invade and colonize epithelial cells. This allows P. gingivalis to persist and to
avoid destruction from the host’s immune response. Previous studies, through the use of
hybridization arrays, have shown the rag locus to be a potential virulence factor in
invasion. It has recently been shown the rag locus to be essential for viability in vitro
using a mariner transposon system in P. gingivalis strain 33277 [72]. RagB may aid P.
gingivalis in attachment to the host, modification of host membrane proteins for
internalization, or survival once internalized within the host cell. We show ragB mutants
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were unable to colonize the immortalized oral epithelial cell line, TIGK, using an
antibiotic protection assay. The exact role ragB plays in invasion is still unknown and
additional experiments are required. One approach would be to use fluorescent labeled P.
gingivalis to infect TIGKs using confocal microscopy to visualize interactions in realtime. An alternative approach would be to perform an invasion assay without the use of
antibiotics, and count CFUs to determine if ragB aids in attachment. RagB may
potentially be used as a target to block entry and/or attachment to host cells.
Two previous studies have examined rag mutants using murine soft tissue
models, which are used to measure inflammatory potential of bacterial strains injected
dorsal subcutaneously. They showed rag mutants displayed a reduction in inflammatory
lesion size, lower CFU recovery in the spleen and increased mice survival rate when
compared to the wild type strain [74, 75]. These results correlate with our study,
demonstrating the ragB mutant exhibits a reduction in inflammatory potential compared
to the parental strain.
An alternative in vivo model available is the alveolar bone loss model [130]. The
bone loss model allows for investigations of bacterial induced bone-loss in the oral
cavity, bacterial burden of the oral cavity, neutrophil recruitment in the gingival tissue
and systemic inflammatory mediators in the blood. Additionally, murine dorsal
subcutaneous chamber model can be utilized to measure inflammatory responses to
agonists of interest. Metal chambers are implanted in the backs of mice that allow for an
environment in which to measure cytokine production, neutrophil infiltration, and
bacterial growth within the chamber [136]. The rag mutants would be a good candidate
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for both models. We would be able to determine the inflammatory potential of rag genes
in an in vivo model and the role rag plays in the progression of periodontitis.

Summary
In summary, RagB is a major pro-inflammatory protein of P. gingivalis that is
recognized by human TLR2 and TLR4. We have shown RagB to induce proinflammatory cytokines in a p65 and STAT4 dependent manner. We also show the
inflammatory potential of ragB in context of the whole bacterium. The exact role RagB
contributes in bacterial physiology is still unknown, although, we hope the crystal
structure yields targets of interest for future investigations. We also show RagB plays a
potentially major role in the colonization of TIGK cells which warrants further
investigation into the mechanisms involved. We conclude RagB is a major virulence
factor of P. gingivalis and may serve as a potential therapeutic target for P. gingivalis
induced diseases.

67

REFERENCES

1.

2.
3.

4.
5.

6.
7.

8.

9.
10.

11.

12.

13.
14.

15.

16.

Ray, A. and K.E. Prefontaine, Physical association and functional antagonism
between the p65 subunit of transcription factor NF-kappa B and the
glucocorticoid receptor. Proceedings of the National Academy of Sciences of the
United States of America, 1994. 91(2): p. 752-6.
Sternberg, E.M., Neural regulation of innate immunity: a coordinated nonspecific
host response to pathogens. Nature reviews. Immunology, 2006. 6(4): p. 318-28.
Straub, R.H., et al., Energy regulation and neuroendocrine-immune control in
chronic inflammatory diseases. Journal of internal medicine, 2010. 267(6): p.
543-60.
Ogden, C.L., et al., Prevalence of childhood and adult obesity in the United
States, 2011-2012. JAMA, 2014. 311(8): p. 806-14.
Yamamoto, Y. and R.B. Gaynor, Therapeutic potential of inhibition of the NFkappaB pathway in the treatment of inflammation and cancer. The Journal of
clinical investigation, 2001. 107(2): p. 135-42.
Madonna, G., et al., NF-kappaB as potential target in the treatment of melanoma.
Journal of translational medicine, 2012. 10: p. 53.
Ciarcia, R., et al., Imatinib treatment inhibit IL-6, IL-8, NF-KB and AP-1
production and modulate intracellular calcium in CML patients. Journal of
cellular physiology, 2012. 227(6): p. 2798-803.
Capiralla, H., et al., Resveratrol mitigates lipopolysaccharide- and Abetamediated microglial inflammation by inhibiting the TLR4/NF-kappaB/STAT
signaling cascade. J Neurochem, 2012. 120(3): p. 461-72.
de Goer de Herve, M.G., et al., Interferon-alpha triggers B cell effector 1 (Be1)
commitment. PLoS One, 2011. 6(4): p. e19366.
O'Malley, J.T., et al., Signal transducer and activator of transcription 4 limits the
development of adaptive regulatory T cells. Immunology, 2009. 127(4): p. 58795.
Walker, J.G., et al., Characterisation of a dendritic cell subset in synovial tissue
which strongly expresses Jak/STAT transcription factors from patients with
rheumatoid arthritis. Ann Rheum Dis, 2007. 66(8): p. 992-9.
O'Malley, J.T., et al., STAT4 isoforms differentially regulate Th1 cytokine
production and the severity of inflammatory bowel disease. J Immunol, 2008.
181(7): p. 5062-70.
Yang, Z., et al., Autoimmune diabetes is blocked in Stat4-deficient mice. J
Autoimmun, 2004. 22(3): p. 191-200.
Chen, M., et al., Lisofylline, a novel antiinflammatory agent, protects pancreatic
beta-cells from proinflammatory cytokine damage by promoting mitochondrial
metabolism. Endocrinology, 2002. 143(6): p. 2341-8.
Yang, Z., et al., The novel anti-inflammatory compound, lisofylline, prevents
diabetes in multiple low-dose streptozotocin-treated mice. Pancreas, 2003. 26(4):
p. e99-104.
Petersen, P.E., et al., The global burden of oral diseases and risks to oral health.
Bull World Health Organ, 2005. 83(9): p. 661-9.
68

17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.

29.

30.

31.

32.
33.
34.
35.

36.

Brown, L.J., B.A. Johns, and T.P. Wall, The economics of periodontal diseases.
Periodontology 2000, 2002. 29: p. 223-34.
Brown, L.J. and H. Loe, Prevalence, extent, severity and progression of
periodontal disease. Periodontology 2000, 1993. 2: p. 57-71.
Eke, P.I., et al., Prevalence of periodontitis in adults in the United States: 2009
and 2010. Journal of dental research, 2012. 91(10): p. 914-20.
Kinane, D.F. and I.G. Chestnutt, Relationship of diabetes to periodontitis. Current
opinion in periodontology, 1997. 4: p. 29-34.
Bergstrom, J., Cigarette smoking as risk factor in chronic periodontal disease.
Community dentistry and oral epidemiology, 1989. 17(5): p. 245-7.
Tanner, A.C., et al., Clinical and other risk indicators for early periodontitis in
adults. Journal of periodontology, 2005. 76(4): p. 573-81.
Van Dyke, T.E. and D. Sheilesh, Risk factors for periodontitis. Journal of the
International Academy of Periodontology, 2005. 7(1): p. 3-7.
Calsina, G., J.M. Ramon, and J.J. Echeverria, Effects of smoking on periodontal
tissues. Journal of clinical periodontology, 2002. 29(8): p. 771-6.
Baljoon, M., S. Natto, and J. Bergstrom, Long-term effect of smoking on vertical
periodontal bone loss. Journal of clinical periodontology, 2005. 32(7): p. 789-97.
Kumar, P.S., et al., Tobacco smoking affects bacterial acquisition and
colonization in oral biofilms. Infection and immunity, 2011. 79(11): p. 4730-8.
Marsh, P.D., Microbial ecology of dental plaque and its significance in health and
disease. Advances in dental research, 1994. 8(2): p. 263-71.
Palmer, R.J., Jr., et al., Mutualism versus independence: strategies of mixedspecies oral biofilms in vitro using saliva as the sole nutrient source. Infection
and immunity, 2001. 69(9): p. 5794-804.
Bradshaw, D.J., et al., Effect of oxygen, inoculum composition and flow rate on
development of mixed-culture oral biofilms. Microbiology, 1996. 142 ( Pt 3): p.
623-9.
Scannapieco, F.A., R.B. Bush, and S. Paju, Associations between periodontal
disease and risk for atherosclerosis, cardiovascular disease, and stroke. A
systematic review. Annals of periodontology / the American Academy of
Periodontology, 2003. 8(1): p. 38-53.
Demmer, R.T. and M. Desvarieux, Periodontal infections and cardiovascular
disease: the heart of the matter. Journal of the American Dental Association,
2006. 137 Suppl: p. 14S-20S; quiz 38S.
Paju, S. and F.A. Scannapieco, Oral biofilms, periodontitis, and pulmonary
infections. Oral diseases, 2007. 13(6): p. 508-12.
Bansal, M., M. Khatri, and V. Taneja, Potential role of periodontal infection in
respiratory diseases - a review. Journal of medicine and life, 2013. 6(3): p. 244-8.
Detert, J., et al., The association between rheumatoid arthritis and periodontal
disease. Arthritis research & therapy, 2010. 12(5): p. 218.
Saini, R., S. Saini, and S.R. Saini, Periodontitis: A risk for delivery of premature
labor and low-birth-weight infants. Journal of natural science, biology, and
medicine, 2010. 1(1): p. 40-2.
Ikegami, A., P. Chung, and Y.W. Han, Complementation of the fadA mutation in
Fusobacterium nucleatum demonstrates that the surface-exposed adhesin
69

37.

38.

39.

40.

41.
42.

43.
44.

45.
46.

47.
48.

49.

50.

51.

promotes cellular invasion and placental colonization. Infection and immunity,
2009. 77(7): p. 3075-9.
Shanthi, V., et al., Association of pregnant women periodontal status to preterm
and low-birth weight babies: A systematic and evidence-based review. Dental
research journal, 2012. 9(4): p. 368-80.
Holt, S.C. and J.L. Ebersole, Porphyromonas gingivalis, Treponema denticola,
and Tannerella forsythia: the "red complex", a prototype polybacterial
pathogenic consortium in periodontitis. Periodontology 2000, 2005. 38: p. 72122.
Hajishengallis, G., et al., Low-abundance biofilm species orchestrates
inflammatory periodontal disease through the commensal microbiota and
complement. Cell host & microbe, 2011. 10(5): p. 497-506.
Maekawa, T., et al., Porphyromonas gingivalis manipulates complement and TLR
signaling to uncouple bacterial clearance from inflammation and promote
dysbiosis. Cell Host Microbe, 2014. 15(6): p. 768-78.
Hajishengallis, G., R.P. Darveau, and M.A. Curtis, The keystone-pathogen
hypothesis. Nature reviews. Microbiology, 2012.
Shapira, L., S. Ayalon, and T. Brenner, Effects of Porphyromonas gingivalis on
the central nervous system: activation of glial cells and exacerbation of
experimental autoimmune encephalomyelitis. Journal of periodontology, 2002.
73(5): p. 511-6.
Imamura, T., The role of gingipains in the pathogenesis of periodontal disease.
Journal of periodontology, 2003. 74(1): p. 111-8.
Shah, H.N. and S.E. Gharbia, Ecological events in subgingival dental plaque with
reference to Bacteroides and Fusobacterium species. Infection, 1989. 17(4): p.
264-8.
Holt, S.C., et al., Virulence factors of Porphyromonas gingivalis. Periodontol
2000, 1999. 20: p. 168-238.
Laine, M.L., B.J. Appelmelk, and A.J. van Winkelhoff, Novel polysaccharide
capsular serotypes in Porphyromonas gingivalis. J Periodontal Res, 1996. 31(4):
p. 278-84.
van Winkelhoff, A.J., et al., K-antigens in Porphyromonas gingivalis are
associated with virulence. Oral Microbiol Immunol, 1993. 8(5): p. 259-65.
Vernal, R., et al., Distinct human T-lymphocyte responses triggered by
Porphyromonas gingivalis capsular serotypes. J Clin Periodontol, 2014. 41(1): p.
19-30.
Irshad, M., et al., In vitro invasion and survival of Porphyromonas gingivalis in
gingival fibroblasts; role of the capsule. Arch Immunol Ther Exp (Warsz), 2012.
60(6): p. 469-76.
Singh, A., et al., The capsule of Porphyromonas gingivalis leads to a reduction in
the host inflammatory response, evasion of phagocytosis, and increase in
virulence. Infect Immun, 2011. 79(11): p. 4533-42.
Potempa, J., R. Pike, and J. Travis, The multiple forms of trypsin-like activity
present in various strains of Porphyromonas gingivalis are due to the presence of
either Arg-gingipain or Lys-gingipain. Infection and immunity, 1995. 63(4): p.
1176-82.
70

52.

53.
54.

55.
56.

57.

58.

59.

60.

61.
62.
63.
64.

65.
66.

67.

Nakayama, K., et al., Construction and characterization of arginine-specific
cysteine proteinase (Arg-gingipain)-deficient mutants of Porphyromonas
gingivalis. Evidence for significant contribution of Arg-gingipain to virulence.
The Journal of biological chemistry, 1995. 270(40): p. 23619-26.
Bao, K., et al., Role of Porphyromonas gingivalis gingipains in multi-species
biofilm formation. BMC microbiology, 2014. 14: p. 258.
Yamatake, K., et al., Role for gingipains in Porphyromonas gingivalis traffic to
phagolysosomes and survival in human aortic endothelial cells. Infect Immun,
2007. 75(5): p. 2090-100.
Popadiak, K., et al., Biphasic effect of gingipains from Porphyromonas gingivalis
on the human complement system. J Immunol, 2007. 178(11): p. 7242-50.
Sugawara, S., et al., Proteolysis of human monocyte CD14 by cysteine proteinases
(gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide
hyporesponsiveness. J Immunol, 2000. 165(1): p. 411-8.
Kumada, H., et al., Structural study on the free lipid A isolated from
lipopolysaccharide of Porphyromonas gingivalis. Journal of bacteriology, 1995.
177(8): p. 2098-106.
Darveau, R.P., et al., Porphyromonas gingivalis lipopolysaccharide contains
multiple lipid A species that functionally interact with both toll-like receptors 2
and 4. Infection and immunity, 2004. 72(9): p. 5041-51.
Herath, T.D., et al., Tetra- and penta-acylated lipid A structures of
Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-kappaB
signal transduction cascade and immuno-inflammatory response in human
gingival fibroblasts. PLoS One, 2013. 8(3): p. e58496.
Herath, T.D., et al., Porphyromonas gingivalis lipopolysaccharide lipid A
heterogeneity differentially modulates the expression of IL-6 and IL-8 in human
gingival fibroblasts. J Clin Periodontol, 2011. 38(8): p. 694-701.
Hamada, N., et al., Isolation and characterization of a minor fimbria from
Porphyromonas gingivalis. Infection and immunity, 1996. 64(11): p. 4788-94.
Hamada, N., et al., Construction and characterization of a fimA mutant of
Porphyromonas gingivalis. Infection and immunity, 1994. 62(5): p. 1696-704.
Njoroge, T., et al., A role for fimbriae in Porphyromonas gingivalis invasion of
oral epithelial cells. Infect Immun, 1997. 65(5): p. 1980-4.
Wright, C.J., et al., Disruption of heterotypic community development by
Porphyromonas gingivalis with small molecule inhibitors. Mol Oral Microbiol,
2014. 29(5): p. 185-93.
Bagaitkar, J., et al., Tobacco upregulates P. gingivalis fimbrial proteins which
induce TLR2 hyposensitivity. PloS one, 2010. 5(5): p. e9323.
Hajishengallis, G., M. Wang, and S. Liang, Induction of distinct TLR2-mediated
proinflammatory and proadhesive signaling pathways in response to
Porphyromonas gingivalis fimbriae. J Immunol, 2009. 182(11): p. 6690-6.
Zeituni, A.E., et al., The native 67-kilodalton minor fimbria of Porphyromonas
gingivalis is a novel glycoprotein with DC-SIGN-targeting motifs. J Bacteriol,
2010. 192(16): p. 4103-10.

71

68.

69.

70.

71.

72.
73.

74.

75.

76.

77.

78.
79.
80.
81.

82.
83.
84.

Curtis, M.A., S.A. Hanley, and J. Aduse-Opoku, The rag locus of Porphyromonas
gingivalis: a novel pathogenicity island. Journal of periodontal research, 1999.
34(7): p. 400-5.
Reeves, A.R., et al., A Bacteroides thetaiotaomicron outer membrane protein that
is essential for utilization of maltooligosaccharides and starch. Journal of
bacteriology, 1996. 178(3): p. 823-30.
Hanley, S.A., J. Aduse-Opoku, and M.A. Curtis, A 55-kilodalton
immunodominant antigen of Porphyromonas gingivalis W50 has arisen via
horizontal gene transfer. Infection and immunity, 1999. 67(3): p. 1157-71.
Curtis, M.A., et al., Identification of the major surface protein antigens of
Porphyromonas gingivalis using IgG antibody reactivity of periodontal casecontrol serum. Oral microbiology and immunology, 1991. 6(6): p. 321-6.
Klein, B.A., et al., Identification of essential genes of the periodontal pathogen
Porphyromonas gingivalis. BMC Genomics, 2012. 13: p. 578.
Imai, M., et al., Major outer membrane proteins from Porphyromonas gingivalis:
strain variation, distribution, and clinical significance in periradicular lesions.
European journal of oral sciences, 2005. 113(5): p. 391-9.
Nagano, K., et al., Characterization of RagA and RagB in Porphyromonas
gingivalis: study using gene-deletion mutants. Journal of medical microbiology,
2007. 56(Pt 11): p. 1536-48.
Shi, X., et al., The rag locus of Porphyromonas gingivalis contributes to virulence
in a murine model of soft tissue destruction. Infection and immunity, 2007. 75(4):
p. 2071-4.
Zheng, D., et al., Enhancing specific-antibody production to the ragB vaccine
with GITRL that expand Tfh, IFN-gamma(+) T cells and attenuates
Porphyromonas gingivalis infection in mice. PloS one, 2013. 8(4): p. e59604.
Rodrigues, P.H. and A. Progulske-Fox, Gene expression profile analysis of
Porphyromonas gingivalis during invasion of human coronary artery endothelial
cells. Infection and immunity, 2005. 73(9): p. 6169-73.
Mackey, D. and A.J. McFall, MAMPs and MIMPs: proposed classifications for
inducers of innate immunity. Molecular microbiology, 2006. 61(6): p. 1365-71.
Zelensky, A.N. and J.E. Gready, The C-type lectin-like domain superfamily. The
FEBS journal, 2005. 272(24): p. 6179-217.
Ye, Z. and J.P. Ting, NLR, the nucleotide-binding domain leucine-rich repeat
containing gene family. Current opinion in immunology, 2008. 20(1): p. 3-9.
Onoguchi, K., M. Yoneyama, and T. Fujita, Retinoic acid-inducible gene-I-like
receptors. Journal of interferon & cytokine research : the official journal of the
International Society for Interferon and Cytokine Research, 2011. 31(1): p. 27-31.
Medzhitov, R., Toll-like receptors and innate immunity. Nature reviews.
Immunology, 2001. 1(2): p. 135-45.
Janeway, C.A., Jr. and R. Medzhitov, Innate immune recognition. Annual review
of immunology, 2002. 20: p. 197-216.
Rakoff-Nahoum, S. and R. Medzhitov, Toll-like receptors and cancer. Nature
reviews. Cancer, 2009. 9(1): p. 57-63.

72

85.

86.

87.
88.

89.
90.
91.
92.
93.
94.
95.

96.
97.

98.

99.

100.

101.

Chow, J.C., et al., Toll-like receptor-4 mediates lipopolysaccharide-induced
signal transduction. The Journal of biological chemistry, 1999. 274(16): p.
10689-92.
Yoneda, K., et al., Dual topology of functional Toll-like receptor 3 expression in
human hepatocellular carcinoma: differential signaling mechanisms of TLR3induced NF-kappaB activation and apoptosis. International journal of oncology,
2008. 33(5): p. 929-36.
Yamamoto, M., et al., Role of adaptor TRIF in the MyD88-independent toll-like
receptor signaling pathway. Science, 2003. 301(5633): p. 640-3.
Vallabhapurapu, S. and M. Karin, Regulation and function of NF-kappaB
transcription factors in the immune system. Annual review of immunology, 2009.
27: p. 693-733.
Kagan, J.C., et al., TRAM couples endocytosis of Toll-like receptor 4 to the
induction of interferon-beta. Nature immunology, 2008. 9(4): p. 361-8.
Akira, S., S. Uematsu, and O. Takeuchi, Pathogen recognition and innate
immunity. Cell, 2006. 124(4): p. 783-801.
Takeda, K. and S. Akira, Toll-like receptors in innate immunity. International
immunology, 2005. 17(1): p. 1-14.
Takeda, K., Evolution and integration of innate immune recognition systems: the
Toll-like receptors. Journal of endotoxin research, 2005. 11(1): p. 51-5.
Duesbery, N.S., et al., Proteolytic inactivation of MAP-kinase-kinase by anthrax
lethal factor. Science, 1998. 280(5364): p. 734-7.
Sanada, T., et al., The Shigella flexneri effector OspI deamidates UBC13 to
dampen the inflammatory response. Nature, 2012. 483(7391): p. 623-6.
Zhang, Z., et al., The role of C-terminal tyrosine phosphorylation in the
regulation of SHP-1 explored via expressed protein ligation. The Journal of
biological chemistry, 2003. 278(7): p. 4668-74.
Goodman, A.L., et al., Identifying genetic determinants needed to establish a
human gut symbiont in its habitat. Cell Host Microbe, 2009. 6(3): p. 279-89.
O'Hara, A.M., et al., Tumor necrosis factor (TNF)-alpha-induced IL-8 expression
in gastric epithelial cells: role of reactive oxygen species and AP endonuclease1/redox factor (Ref)-1. Cytokine, 2009. 46(3): p. 359-69.
Livak, K.J. and T.D. Schmittgen, Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001.
25(4): p. 402-8.
Zhang, P., et al., TLR2-dependent modulation of osteoclastogenesis by
Porphyromonas gingivalis through differential induction of NFATc1 and NFkappaB. J Biol Chem, 2011. 286(27): p. 24159-69.
Kim, H.S. and D.H. Chung, TLR4-mediated IL-12 production enhances IFNgamma and IL-1beta production, which inhibits TGF-beta production and
promotes antibody-induced joint inflammation. Arthritis Res Ther, 2012. 14(5): p.
R210.
Gibson, F.C., 3rd and C.A. Genco, Porphyromonas gingivalis mediated
periodontal disease and atherosclerosis: disparate diseases with commonalities in
pathogenesis through TLRs. Current pharmaceutical design, 2007. 13(36): p.
3665-75.
73

102.

103.

104.

105.
106.

107.

108.

109.
110.

111.

112.

113.

114.

115.

116.
117.

Fukao, T., et al., Inducible expression of Stat4 in dendritic cells and macrophages
and its critical role in innate and adaptive immune responses. J Immunol, 2001.
166(7): p. 4446-55.
Hochrainer, K., G. Racchumi, and J. Anrather, Site-specific phosphorylation of
the p65 protein subunit mediates selective gene expression by differential NFkappaB and RNA polymerase II promoter recruitment. J Biol Chem, 2013.
288(1): p. 285-93.
Morinobu, A., et al., STAT4 serine phosphorylation is critical for IL-12-induced
IFN-gamma production but not for cell proliferation. Proc Natl Acad Sci U S A,
2002. 99(19): p. 12281-6.
Remoli, M.E., et al., NF-{kappa}B is required for STAT-4 expression during
dendritic cell maturation. Journal of leukocyte biology, 2007. 81(1): p. 355-63.
Jayaprakash, K., H. Khalaf, and T. Bengtsson, Gingipains from Porphyromonas
gingivalis play a significant role in induction and regulation of CXCL8 in THP-1
cells. BMC Microbiol, 2014. 14: p. 193.
Jiang, S.J., et al., Identification and characterization of Chlamydia pneumoniaespecific proteins that activate tumor necrosis factor alpha production in RAW
264.7 murine macrophages. Infect Immun, 2008. 76(4): p. 1558-64.
Anaya-Bergman, C., et al., Porphyromonas gingivalis ferrous iron transporter
FeoB1 influences sensitivity to oxidative stress. Infect Immun, 2010. 78(2): p.
688-96.
Bagaitkar, J., et al., Tobacco-induced alterations to Porphyromonas gingivalishost interactions. Environmental microbiology, 2009. 11(5): p. 1242-53.
Bonass, W.A., et al., Identification of ragAB as a temperature-regulated operon
of Porphyromonas gingivalis W50 using differential display of randomly primed
RNA. Infection and immunity, 2000. 68(7): p. 4012-7.
Phansopa, C., et al., Structural and functional characterization of NanU, a novel
high-affinity sialic acid-inducible binding protein of oral and gut-dwelling
Bacteroidetes species. The Biochemical journal, 2014. 458(3): p. 499-511.
Wei, B., et al., Molecular cloning of a Bacteroides caccae TonB-linked outer
membrane protein identified by an inflammatory bowel disease marker antibody.
Infection and immunity, 2001. 69(10): p. 6044-54.
Dolgilevich, S., et al., Genomic comparison of invasive and rare non-invasive
strains reveals Porphyromonas gingivalis genetic polymorphisms. Journal of oral
microbiology, 2011. 3.
Schildberger, A., et al., Monocytes, peripheral blood mononuclear cells, and
THP-1 cells exhibit different cytokine expression patterns following stimulation
with lipopolysaccharide. Mediators Inflamm, 2013. 2013: p. 697972.
Ding, P.H., et al., Porphyromonas gingivalis LPS stimulates the expression of
LPS-binding protein in human oral keratinocytes in vitro. Innate Immun, 2013.
19(1): p. 66-75.
Ronnblom, L., The type I interferon system in the etiopathogenesis of autoimmune
diseases. Upsala journal of medical sciences, 2011. 116(4): p. 227-37.
Guo, L., et al., IL-1 family members and STAT activators induce cytokine
production by Th2, Th17, and Th1 cells. Proceedings of the National Academy of
Sciences of the United States of America, 2009. 106(32): p. 13463-8.
74

118.

119.

120.

121.
122.

123.

124.

125.
126.

127.

128.

129.

130.

131.
132.
133.

Frucht, D.M., et al., Stat4 is expressed in activated peripheral blood monocytes,
dendritic cells, and macrophages at sites of Th1-mediated inflammation. J
Immunol, 2000. 164(9): p. 4659-64.
Matsukawa, A., et al., Pivotal role of signal transducer and activator of
transcription (Stat)4 and Stat6 in the innate immune response during sepsis. The
Journal of experimental medicine, 2001. 193(6): p. 679-88.
Good, S.R., et al., Temporal induction pattern of STAT4 target genes defines
potential for Th1 lineage-specific programming. Journal of immunology, 2009.
183(6): p. 3839-47.
Lawless, V.A., et al., Stat4 regulates multiple components of IFN-gammainducing signaling pathways. J Immunol, 2000. 165(12): p. 6803-8.
Negishi, M., et al., Lipopolysaccharide (LPS)-induced Interferon (IFN)-gamma
production by decidual mononuclear cells (DMNC) is interleukin (IL)-2 and IL12 dependent. Am J Reprod Immunol, 2011. 65(1): p. 20-7.
Smeltz, R.B., et al., Role of IFN-gamma in Th1 differentiation: IFN-gamma
regulates IL-18R alpha expression by preventing the negative effects of IL-4 and
by inducing/maintaining IL-12 receptor beta 2 expression. J Immunol, 2002.
168(12): p. 6165-72.
Gujer, C., et al., IFN-alpha produced by human plasmacytoid dendritic cells
enhances T cell-dependent naive B cell differentiation. J Leukoc Biol, 2011.
89(6): p. 811-21.
Grohmann, U., et al., Positive regulatory role of IL-12 in macrophages and
modulation by IFN-gamma. Journal of immunology, 2001. 167(1): p. 221-7.
Chao, Y. and T. Zhang, Optimization of fixation methods for observation of
bacterial cell morphology and surface ultrastructures by atomic force
microscopy. Applied microbiology and biotechnology, 2011. 92(2): p. 381-92.
Moffatt-Jauregui, C.E., et al., Establishment and characterization of a telomerase
immortalized human gingival epithelial cell line. Journal of periodontal research,
2013.
Inaba, H., et al., Heterogenic virulence and related factors among clinical isolates
of Porphyromonas gingivalis with type II fimbriae. Oral Microbiol Immunol,
2008. 23(1): p. 29-35.
Bakolitsa, C., et al., Structure of BT_3984, a member of the SusD/RagB family of
nutrient-binding molecules. Acta crystallographica. Section F, Structural biology
and crystallization communications, 2010. 66(Pt 10): p. 1274-80.
Baker, P.J., R.T. Evans, and D.C. Roopenian, Oral infection with Porphyromonas
gingivalis and induced alveolar bone loss in immunocompetent and severe
combined immunodeficient mice. Archives of oral biology, 1994. 39(12): p. 103540.
Adamowicz, K., et al., Inhibition of GSK3 abolishes bacterial-induced
periodontal bone loss in mice. Mol Med, 2012. 18: p. 1190-6.
Martin, M., et al., Toll-like receptor-mediated cytokine production is differentially
regulated by glycogen synthase kinase 3. Nat Immunol, 2005. 6(8): p. 777-84.
Tang, D.C., M. DeVit, and S.A. Johnston, Genetic immunization is a simple
method for eliciting an immune response. Nature, 1992. 356(6365): p. 152-4.

75

134.
135.

136.

Hall, L.M., et al., Sequence diversity and antigenic variation at the rag locus of
Porphyromonas gingivalis. Infection and immunity, 2005. 73(7): p. 4253-62.
Luckay, A., et al., Effect of plasmid DNA vaccine design and in vivo
electroporation on the resulting vaccine-specific immune responses in rhesus
macaques. J Virol, 2007. 81(10): p. 5257-69.
Lin, Y.Y., et al., Tissue destruction induced by Porphyromonas gingivalis
infection in a mouse chamber model is associated with host tumor necrosis factor
generation. Infection and immunity, 2005. 73(12): p. 7946-52.

76

CURRICULUM VITAE

Justin Hutcherson
1511 Regency Woods Rd. Apt. 302
Henrico, VA 23238
Cell: (731) 514-0543
Postdoctoral Fellow, Virginia Commonwealth University
Email: jahutcherson@vcu.edu , hutch1407@gmail.com
Education/Training:
Postdoctoral Fellow, Virginia Commonwealth University, VA (2015-present)
Ph. D Candidate Microbiology & Immunology, University of Louisville, KY (20102014)
M.S., Microbiology & Immunology, University of Louisville, KY (2012)
M.S., Biology, Middle Tennessee State University, Murfreesboro, TN (2008-2010)
B.S., Biology, University of Tennessee at Martin, TN (2004-2008)
Research Experience:
Primary doctoral project: Investigation of host-pathogen interactions in periodontal
inflammatory diseases. Including bacterial virulence factors and their role in activation
and suppression of the innate immune response.
Skilled in microbiological, immunological, and cell molecular techniques including
protein expression and isolation, microarray technology, Tn-Seq, murine model of
infection, etc.
Proficient in independent planning and working multiple projects concurrently.
Awards/Honors:
Treasurer (2013), American International Relations Club (AIRC), University of
Louisville, KY
President (2011-2012), Microbiology and Immunology Student Association; invited and
organized distinguished speaker – Dr. John Connor, Boston University School of
Medicine
Integrated Programs in Biomedical Sciences (IPIBS) Pre-doctoral Fellowship, University
of Louisville, 2010-2012
77

Mentorship/Teaching Experience:
Mentorship:
Rajarshi Guhaniyogi, first year dental Master’s student (School of Dentistry,
University of Louisville), 6/2014-12/2014. “Cannabidiol suppresses the innate immune
response to oral pathogens”.
Himabindu Gogeneni, second year dental Master’s student (School of Dentistry,
University of Louisville), 5/2013-12/2014. “Identification of genes essential for the
survival of cigarette smoke-exposed Porphyromonas gingivalis”.
Lead Graduate Teaching Assistant (2009-2010), Middle Tennessee State University
Biology Department; Mentored Graduate Teaching Assistants.
Graduate Teaching Assistant (2008-2010), Middle Tennessee State University Biology
Department; Taught undergraduate biology labs.
Volunteer Work:
Poster Judge (2014), Research Louisville, University of Louisville, Louisville, KY
Poster Judge (2014), Dupont Manual Science Fair, Louisville, KY
Poster Judge (2013), Dupont Manual Science Fair, Louisville, KY
First Responder (2005-2009), Weakly County Ambulance Service, Dresden, TN
Firefighter (2004-2009), Dresden Fire Department, Dresden, TN
Presentations:
October 2014 Poster presentation, 13th Annual Brown Cancer Center Retreat, Louisville,
KY
October 2013 Poster presentation, 12th Annual Brown Cancer Center Retreat, Louisville,
KY
September 2013 Poster presentation, Research Louisville, University of Louisville,
Louisville, KY
July 2013 Poster presentation at 5th Congress of Federation of European Microbiologists,
Leipzig, Germany
March 2013 Oral and Poster Presentation, 5th Annual Graduate Research Symposium,
Louisville, KY

78

October 2012 Poster presentation, 11th Annual Brown Cancer Center Retreat, Louisville,
KY
September 2012 Poster presentation, Research Louisville, University of Louisville,
Louisville, KY
April 2010, Poster presentation, Graduate Symposium, Middle Tennessee State
University, Murfreesboro, TN
Publications:
HUTCHERSON JA, GONENI H, YODER-HIMES D, HENDRICKSON EL,
HACKETT, LAMONT RJ, SCOTT DA. Comparison of inherently essential genes of
Porphyromonas gingivalis identified in two transposon sequencing libraries. FEMS
Microbiology Letters. (Manuscript in preparation)
HUTCHERSON JA, SCOTT DA, BAGAITKAR, J. Scratching the surface-tobaccoinduced bacterial biofilms. Tobacco Induced Diseases. 2015 Feb 10;13(1):1
HUTCHERSON JA, BAGAITKAR J, NAGANO K, YOSIMURA, WANG H, SCOTT
DA. Porphyromonas gingivalis RagB is a pro-inflammatory STAT4 agonist. Molecular
Oral Microbiology. 2015 JAN; DOI: 10.1111/omi.12089
ZELLER I, HUTCHERSON JA, LAMONT RJ,DEMUTH DR, GUMUS P, NIZAM N,
BUDUNELI N, SCOTT DA. Smoking alters the antigenicity and infectivity of
Porphyromonas gingivalis. Journal of Periodontology, 2014 Jun; 85(6): 837-44.

79

